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Abstract
Type 2 diabetes is a population health problem and a leading cause of mortality in the
United States. The complications and comorbidities associated with diabetes cause a
financial and resource burden on the healthcare system and negative mental and physical
health outcomes for the individuals living with the disease. The clinical practice problem
addressed by this project was glycemic control following an orthopedic surgery requiring
hospitalization. The project was informed by the chronic care model, which emphasizes
the need for a whole system, interdisciplinary team approach to disease management and
prevention of complications. To analyze the practice problem and create an evidencebased clinical practice guideline to direct patient care, a literature review was completed.
Literature was reviewed and graded using the Oxford Centre for Evidence-Based
Medicine Levels of Evidence. Professional organizations’ guidelines and scholarly
publications were also reviewed in developing the guideline. Central themes from the
literature review were translated into the clinical practice guideline and included the
importance of long-term preoperative glycemic control, patients’ skills for selfmanagement, and mental health evaluation and support of patients. To ensure the
appropriateness of the clinical practice guideline for translation into practice, the AGREE
II tool was applied by the author in the guideline development and used by the project
team in evaluation of the guideline for adoption. Improving postoperative glycemic
control for patients living with type 2 diabetes supports social change by improving the
patients’ ability to contribute to society, decreasing the healthcare burden, and addressing
the mental and physical health of patients.
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Section 1: Nature of the Project
Introduction
In the United States, as of 2015, 30.3 million people are affected by diabetes and
an estimated 95% of these cases are classified as type 2 diabetes (American Diabetes
Association [ADA], 2019a). Data show that individuals 65 years of age and older have
the highest prevalence of this diagnosis (ADA, 2019a). However, childhood and young
adults are receiving type 2 diabetes diagnoses at an alarmingly high rate due to obesity,
poor lifestyle choices, and genetic factors (Dutta & Ghosh, 2019). In the United States, as
of 2017, the annual cost of diabetes was an estimated $327 billion (ADA, 2019a). As of
2015, it was the seventh leading cause of death (ADA, 2019a). Public health officials
estimate that type 2 diabetes diagnosis will continually rise at a faster rate, leading to
financial burdens that will bankrupt insurance companies and healthcare institutions
(Maa, 2017).
Type 2 diabetes is a chronic disease with known pathophysiologic and metabolic
changes that contribute to hyperglycemia (Hurtado & Vella, 2019). The pathophysiologic
changes are referred to as the “ominous octet,” as first described by Dr. Ralph DeFranzo,
an esteemed endocrinologist hoping to identify the defects contributing to type 2 diabetes
in order to improve treatment (DeFranzo, Elder, & Abdul-Ghani, 2013). The ominous
octet identifies the following body malfunctions: (a) inadequate release of the hormone
glucagon-like peptide 1 (GLP-1) from the gut, (b) poor release of insulin from the beta
cells in the pancreas, (c) too much glucagon release from the alpha cells of the pancreas,
(d) insulin resistance and the inability of sugar to enter muscle cells, (e) the liver’s
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production of excess sugar in response to glucagon production and insulin resistance, (f)
lack of GLP-1 response by the brain and appetite dysregulation, (g) the insulin resistant
state of fat cells, and (h) excessive reabsorption of sugar from the kidneys returning to the
bloodstream (DeFranzo et al., 2013). These malfunctions contribute to hyperglycemia
and a type 2 diabetes diagnosis.
Many complications and comorbidities are associated with a type 2 diabetes
diagnosis. Type 2 diabetes is known to cause both microvascular and macrovascular
conditions (Hayfron-Benjamin et al., 2019). Microvascular complications include
retinopathy which contributes to blindness, neuropathy which contributes to amputations,
and nephropathy which contributes to chronic kidney disease (Hayfron-Benjamin et al.,
2019). Macrovascular complications include coronary artery disease, increased risk of
myocardial infarction (MI), peripheral vascular disease, and increased risk of
cerebrovascular accident (Hayfron-Benjamin et al., 2019). Common comorbidities
associated with a type 2 diabetes diagnosis include obesity, hypertension, and
hyperlipidemia (Nowakowska et al., 2019). Researchers have also shown correlations
between type 2 diabetes, decreased cognitive functioning, and dementia (Simo, Ciudin,
Sino-Servat, & Hernandez, 2017).
Type 2 diabetes has also been associated with poor quality of life and increased
rates of depression (Gómez-Pimienta et al., 2019). Individuals with a type 2 diabetes
diagnosis are more likely to suffer from multiple medical conditions and have lower
perceived quality of life (Gómez-Pimienta et al., 2018). Additionally, those living with
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type 2 diabetes often face burnout as the disease requires a great amount of self-care and
self-efficacy (Van Smoorenburg et al., 2019).
Type 2 diabetes management requires several pharmacologic and nonpharmacologic interventions (ADA, 2019b). In recent years, the cost of insulin,
injectables, and oral anti-hyperglycemic agents have received much attention (Meng et
al., 2017). The cost of these medications is currently not restricted and, depending on
insurance coverage and other factors, these medications may be unaffordable for some
patients (Meng et al., 2017). Both the American Association of Clinical Endocrinologists
(AACE, 2019b) and ADA (2019b) guidelines illustrate the potential need for three or
more medications for the appropriate management of type 2 diabetes. The financial
burden also extends to the healthcare systems and health insurance companies (Maa,
2017).
Nonpharmacological interventions for the treatment of type 2 diabetes may
include diet, exercise, nutrition therapy, diabetes education, nicotine cessation, stress
relief, and mental health wellness services (ADA, 2019b). These interventions are
important for the treatment of type 2 diabetes and barriers should be eliminated. Many
people associate healthy eating with high-cost foods, therefore, creating a barrier to
healthy eating (Rehm, Monsivais, & Drewnowki, 2015). Food deserts, areas where
certain foods, including fresh fruits and vegetables are not available, compound the
difficulty of improved dietary habits (Schupp, 2019). Exercise requires a lifestyle change
and self-motivation. Many individuals with a type 2 diabetes diagnosis cite lack of
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education and inability to motivate themselves to start an exercise regimen as barriers to
beginning an exercise routine (Jalilian, et al., 2019). Poor exercise regimens may be
associated with comorbidities, time limitations, cost, climate, and functional limitations
(Korkiakangas et al., 2011). Stress relief and mental health in general are under discussed
topics that may have an impact on glycemic control (Armani Kiam et al., 2018). Lack of
mental health resources and stress management education reduce the ability of the person
living with type 2 diabetes from using healthy coping mechanisms to help self-manage
their disease (Armani Kiam et al., 2018). These barriers are especially to discuss and
overcome prior to a surgical procedure.
When speaking of postoperative outcomes, glycemic control is of importance.
Surgical risks, including prolonged healing time and increased length of stay, are
substantially higher when the 90-day average glucose measured via hemoglobin A1C
(HgbA1C) is above 8% (Underwood et al., 2014). For this reason, many surgeons will
not perform nonemergent surgery on a patient with an A1C above 8%. Such a delay in
surgery could lead to prolonged pain, prolonged time away from work, decreased
functioning and mobility, decreased ability to perform activities of daily living,
depression, and poor perceived quality of life (Paul & Issac, 2018). Uncontrolled diabetes
leads to poor outcomes such as longer hospital stays, infection, evisceration or wound
opening, the need for ventilation, admission to the intensive care unit, and mortality
(Yong et al., 2018). These delays contribute to prolonged time away from work, delayed
return to normal activities of daily life, increased depression, prolonged pain, prolonged
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need for pain management therapies, and decreased perceived quality of life (Yong et al.,
2018).
A Doctor of Nursing Practice (DNP) project calls for the standardization and
utilization of a guideline to improve postoperative glycemic control in hospitalized
patients living with type 2 diabetes following orthopedic surgery. Because type 2
diabetes affects a large percentage of the population, it is critical that healthcare providers
are adequately equipped to assist in the management and prevention of postoperative
complications related to glycemic control. From a social perspective, improving
postoperative outcomes allows those with type 2 diabetes a faster return to work and
normal functioning; it also limits the adverse effects on quality of life perception and
depression (Paul & Issac, 2018). Nursing professionals need an improved knowledge
base and a structured guideline to improve advocacy measures, teaching ability, and the
care and treatment of patients living with type 2 diabetes.
Problem Statement
Type 2 diabetes is considered a problem of epidemic proportion and a large
number of surgical patients have a diabetes diagnosis (ADA, 2019a). These patients are
predisposed to altered glycemic control when undergoing a surgical procedure
(Sudhakaran & Surami, 2015). Poor glycemic control is often found postoperatively
because of preoperative changes in eating, medications and anesthesia agents, the
withholding of insulin or alternate antihyperglycemic agents, as well as the metabolic
changes and stress response of the patient undergoing the surgical procedure (Sudhakaran
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& Surani, 2015). Hyperglycemia postoperatively contributes to an array of problems,
including poor wound healing, higher rates of evisceration and infection, longer hospital
stays, an increase in depression, and poorer perceptions of quality of life (Reategui et al.,
2015). Patients often must postpone return to work and have limited ability to perform
activities of daily living (Akiboye & Rayman, 2017). Hyperglycemia has been noted to
continue for 8 months postoperatively if untreated or undermanaged (Akiboye &
Rayman, 2017). Prolonged hyperglycemia contributes to both microvascular and
macrovascular complications, including retinopathy, neuropathy, nephropathy, coronary
artery disease, myocardial infarction, cerebrovascular accident, and peripheral vascular
disease (Hayfron-Benjamin et al., 2019). In addition, hyperglycemia may worsen
comorbidities and increase the risk of infection (Hayfron-Benjamin et al., 2019).
The problem of hyperglycemia following a surgical procedure is seen worldwide
(Aklboye & Rayman, 2017). Delays in hyperglycemia treatment contribute to poor
outcomes (Akiboye & Rayman, 2017). Glycemic management requires specialized
education and an extensive time commitment from the entire healthcare team to ensure
optimal outcomes (Sabione et al., 2018). For this reason, utilization of appropriate
published guidelines that are evidence based, such as those established by the American
Diabetes Association (2019), is critical. Therefore, the focus of the project was to
synthesize the current research and guidelines issued by specialized organizations,
including the ADA (2019b), into a practice guideline. The guideline outlines
recommendations for glycemic control postoperatively in patients living with type 2
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diabetes and who remain in the hospital after an orthopedic procedure. The aim of the
DNP project was to analyze and appraise the research critically to ensure evidence-based
practice methods are used and updated continually.
Purpose Statement
To enhance nursing practice, this project focused on the development of a clinical
practice guideline that synthesized the recommendations and guidelines issued by
reputable sources, which included, but were not limited to, the ADA (2019b), AACE
(2019a), and the Endocrine Society (Umpierrez et al., 2012). The guideline should be
used by all inpatient healthcare providers to ensure appropriate glycemic management of
the patient with type 2 diabetes following an orthopedic surgical procedure requiring an
inpatient stay. Nurses in particular should be aware of the evidence and guidelines to
improve patient care and outcomes. Several evidence-based guidelines have been issued
by reputable organizations, including the Endocrine Society (Umpierrez et al., 2012),
ADA (2019b), and AACE (2019a). However, a synthesis and cohesive report of these
guidelines would allow for improved application consistency (Patrik & Wyckoff, 2018).
Additionally, continued review of research sources should be completed to ensure
continued use of the most up-to-date, high-quality research (Breneman et al., 2015). The
synthesis of the literature, recommendations, and guidelines will create a clear and
concise guide that is evidence based and contains the highest quality research. A clinical
practice guideline allows nurses to provide appropriate care and obtain knowledge on the
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current best practice standards as well as to reduce the gaps and disharmony of care
(Patrick & Wyckoff, 2018).
Nature of the Doctoral Project
Project completion required a robust literature review with great attention to
research validity. The research, current guidelines, and literature will be analyzed
extensively to ensure high quality research. The research findings were translated to fit
the needs of the population: patients with type 2 diabetes postoperatively, who require an
inpatient stay following an orthopedic procedure. A guideline was created by
synthesizing the current guidelines as well as published literature, including specific
details for postoperative patients. The synthesis allowed for creation of a clinical practice
guideline that may be utilized within the clinical settings. This guideline is meant to be
used by all nurses caring for the type 2 diabetic patient following an orthopedic surgery
requiring an inpatient stay. It shall serve as a framework for glycemic management
leading to improvements in perceived quality of life.
Significance
Type 2 diabetes is a significant problem in the United States, affecting nearly 30
million people with an estimated annual cost of $327 billion as of 2015 (ADA, 2019a).
The comorbidities and complications associated with type 2 diabetes increase the
financial burden associated with the diagnosis and the complications following an
orthopedic surgery including longer hospital stays, delays from work, and infections
(Paul & Isaac, 2018). Patients with type 2 diabetes, especially those following an
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orthopedic surgery, confront many challenges that may decrease their perceptions of
quality of life (Yong et al., 2018).
Walden University (2019) established a mission to ensure that doctoral projects
are focused on social change that allows for improvements and maintainable progression
for society and the professions. This social change is expected to come from evidence
and research to ensure the highest quality improvements (Walden University, 2019).
Based on the research, poor postoperative outcomes related to type 2 diabetes have a
grave effect on the individual as well as the society (Akiboye & Rayman, 2017).
Therefore, improvements in outcomes may have a positive benefit on society.
With this project, the profession of nursing will be afforded the opportunity to
continue to grow and develop practice guidelines and ensure the appropriate use of
evidence-based standards to ensure high-quality patient care. Ensuring that an
established guideline can be translated into practice allows for continued development of
the profession and positive societal impacts, including improvements in quality,
evidence-based care. Guidelines are often lengthy and filled with specialty jargon that is
difficult to read and understand (Guo et al., 2016). Providing a synthesis of the
guidelines established by the ADA (2019b) will improve nurses’ ability to use the
guideline. Therefore, nurses will be able to carry out the guideline and improve the care
they provide to patients, and thus promote better patient outcomes.

10
Summary
Type 2 diabetes is a disease millions of Americans are currently living with. The
potential postoperative complications of those living with type 2 diabetes are severe and
could lead to decreased quality of life, depression, debility, and mortality. The established
guidelines offered by the ADA, AACE, and Endocrine Society offer recommendations to
decrease the risk of postoperative complications. However, many patients continue to
suffer from an array of postoperative complications. Guidelines can be difficult to
interpret into practice for a variety of reasons. Producing a clear synthesis of the current
guidelines will contribute to an improved use of the guidelines and thus contribute to
improved patient care, improved glycemic control, decreased risk of complications, and
improvements in perceived quality of life. A clinical practice guideline may be best
created utilizing a model or framework. The guideline is relevant to the local area and the
nursing profession. The student and project team are necessary to ensure clinical practice
guideline development and project completion.
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Section 2: Background and Context
Introduction
Type 2 diabetes is a chronic, progressive disease that may lead to a multitude of
complications and alter a patient’s ability to function (Hurtado & Vella, 2019). Therefore,
adequate treatment is imperative (Akiboye & Rayman, 2017). A professional guideline
for diabetes management across the lifespan and continuum of care is published by the
ADA with annual updates (2019b). The publication includes guidance on management of
diabetes during hospitalization (ADA, 2019b). Though diabetes requires a great deal of
self-management, during times of surgery and hospitalization, the responsibility for
glycemic control includes the healthcare team (Akiboye & Rayman, 2017). Therefore, it
is essential to have an established guideline for use in these circumstances and to ensure
that nurses are educated about the guidelines and recommendations so that they can
advocate for optimal glycemic control (Akiboye & Rayman, 2017). In this section, I
discuss the model that guided the development of the clinical practice guideline, the
development of a clinical practice guideline, its relevance to nursing practice, the local
background and context, and the role of the DNP student.
Model
Concepts are simple words or phrases that act as building blocks and are
commonly used in the nursing profession to strategize, theorize, and analyze (McEwen &
Wills, 2019). To further evaluate glycemic management following an orthopedic surgical
procedure, glycemic management may be seen as a concept. Researchers and scholars are
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able to analyze specific components of glycemic management and explore each
component exclusively and thoroughly. Within the concept of glycemic management,
postoperatively, nurses consider hypoglycemia and hyperglycemia as concepts, as well as
barriers to management. Many other concepts and factors may be dissected to analyze the
situation (Yong et al., 2018).
Models serve as frameworks or guides to address health concerns (McEwen &
Wills, 2019). Many models are used in the management of type 2 diabetes (Crowe, Jones,
Stone, & Coe, 2019). Crowe et al. (2019) offer research showing the improved efficacy
of nurse-led models for the improvement of glycemic control when compared to
physician-led models. The chronic care model (CCM) depicts the need for a whole
system, interdisciplinary team approach for the management of disease and prevention of
complications (Zuccaro, 2015). Type 2 diabetes is a complex, chronic, and progressive
disease requiring the expertise of the individual living with it (Yadmaa, Samoilova, &
Koshevets, 2018). Self-management, as well as the ability to adapt and alter selfmanagement techniques for alternate situations, are imperative for successful disease
management (Yadmaa, Samoilova, & Koshevets, 2018). The model concepts and tenets
allow the application of the CCM in guideline development.
Grover and Joshi (2014) wrote that the CCM includes consideration of the
community, the health system, the person living with diabetes, and the ever-changing
circumstances of life to ensure adequate care and prevention of complications and
ailments. The concepts that guide the care model include the individual, self-
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management, self-efficacy, community, expert, and interdisciplinary care team. The
CCM focuses on entire entities, communities, healthcare systems, technological
advances, and the changing times as these changes are known to affect the way in which
care is delivered and diseases are self-managed. Additionally, the National Committee for
Quality Assurance recognized the importance of the whole system and whole-body
approach to ensure appropriate diabetes management. As diabetes management requires
the person living with the disease, the community, the healthcare system, a network of
medical and healthcare professionals, a wealth of education, and change adaptation skills,
the CCM is a model that is essential to disease management at any stage of life and with
any healthcare challenge, including postoperatively (Grover & Joshi, 2014).
The CCM may be used to assist with clinical practice guideline development as
proposed in this project. To create a guideline for post-orthopedic procedure glycemic
control, all stakeholders must be considered. The guideline must consider the effects of
the guideline on the patient, nurses, the hospital, and the community as a whole because
poor glycemic control and poor patient outcomes affect not only the patient, but also their
family, friends, healthcare providers, healthcare system, and entire community (Funnell,
2006; Paul & Issac, 2018). As guideline review and synthesis progresses, those affected
will be kept at the forefront to ensure the guideline may positively impact patients
throughout the continuum of care and society as a whole.
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Relevance to Nursing Practice
Diabetes is a disease that has reached epidemic proportion in the United States
and according to the World Health Organization (WHO, 2016) incidence rates have
quadrupled since 1980. In the United States, as of 2015, 30.3 million individuals were
living with type 2 diabetes (CDC, 2017b). Of the 30.3 million people living with diabetes,
7.2 million are undiagnosed and unaware of their diagnosis (ADA, 2019a). These
individuals are of varying ethnicities, ages, socioeconomic classes, and areas of residence
(CDC, 2017b). Of the United States population, 9.4% are living with diabetes (CDC,
2017b). Of the individuals living with diabetes, 90% to 95% or approximately 28,785,000
people have a type 2 diabetes diagnosis (WHO, 2019). Comparative data presented by the
CDC (2017a) shows an increase incidence over time in the United States. The incidence
rate of type 2 diabetes in adults was 2.62% in 1985, 3.30% in 1995, 5.61% in 2005, and
7.4% in 2015. The largest incidence rate increase has been noted within the past decade
and this trend is expected to continue. Above and beyond those diagnosed with or living
with diabetes without awareness, 84.1 million people, 33.9% of adults living in the
United States have prediabetes (CDC, 2017b).
CDC (2017b) data shows disparities are noted with type 2 diabetes. Age is a
known health disparity in terms of type 2 diabetes. Prevalence of a diabetes diagnosis is
highest in persons over the age of 45. The 2015 data provided by the CDC (2017b)
showed 10.9 diabetes diagnoses per 1,000 individuals in the 45 to 64 age group. The
second largest prevalence rate is seen among persons in the 65 and older age range with a
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rate of 9.1 diabetes diagnoses per 1,000 individuals. Although many reports suggest a
higher incidence of young adults with a type 2 diabetes diagnosis, the 18–44 age group
has a prevalence rate of 3.1 diagnoses per 1,000 individuals. Women and men do not
have statistically significant differences in prevalence. The prevalence rate for women is
6.8 per 1,000 individuals and the prevalence rate for men is 6.7 per 1,000 individuals.
Disparities are also noted in educational backgrounds with higher prevalence rates of
diabetes among those individuals having lower levels of educational attainment. The
diabetes prevalence rate for individuals without a high school diploma is 12.6%, for
individuals with a high school diploma the rate is 9.3%, and for individuals with a college
degree the rate is 7.2%.
Disparities in ethnicity and residence are also noted. The CDC documented the
prevalence rate of male American Indians and Alaskan Natives as 14.9% and of female
American Indians and Alaskan Natives as 15.3%, which is the highest rate of all
ethnicities. The Black, non-Hispanic prevalence rate is 12.2% for men and 13.2% for
women, and the Hispanic prevalence rates for men is 12.6% and 11.7% for women. The
prevalence rates for the Asian ethnicity is 9% for men and 7.3% for women. The White,
non-Hispanic ethnicity has the lowest prevalence rate, 8.1% for men and 6.8% for
women. Additionally, the CDC documented disparities in the United States based on
residence and reported the highest prevalence rates are seen in the Appalachian areas and
Southern United States.
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The prevalence, increasing incidence, and epidemic proportion complicate disease
management and directly affect the societal impact as well as the significance of the
problem on the nursing profession. The complications and comorbidities associated with
type 2 diabetes further contribute to the problem significance. A number of diseases and
health ailments are associated with diabetes which include but are not limited to
hypertensive disorders, cardiac disorders including the risk for cerebrovascular accident,
myocardial infarction, cardiovascular disease, dyslipidemia, and hypertension, and
obesity (Hayfron-Benjamin et al., 2019). Many comorbidities and complications arise for
microvascular and macrovascular changes caused by hyperglycemia, which include
diabetic retinopathy, nephropathy, neuropathy, blindness, infections, amputations, kidney
disease, pregnancy complications, silent MIs, and cardiac death (Hayfron-Benjamin et al.,
2019). Heart disease is the number one killer of patients living with diabetes (Healthy
People 2020, 2011). Per Healthy People 2020 (2011), diabetes is considered the leading
cause of blindness, lower limb amputations, and renal failure. Type 2 diabetes and the
complications and comorbidities associated with the condition have contributed to the
financial burden of the illness as well. It is estimated that diabetes and diabetes related
illness cost $245 billion annually in the United States.
It is also important to discuss the personal and social impact of type 2 diabetes.
Yadmaa, Samoilova, and Koshevets (2018) offered the direct correlation between a type
2 diabetes diagnosis and psychological maladaptation related to the required behavioral
changes, burden of illness, and financial challenges of the disease. The international
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Diabetes Attitudes, Wellness, and Needs (DAWN) Study was conducted in 13 countries
to evaluate the perceptions, desires, and needs of both individuals living with diabetes and
individuals providing care to those living with diabetes (Funnell, 2006). The study
published by Funnell (2006) had numerous participants which included 2,705 physicians,
both specialists and generalists, 1,122 nurses working in various specialty and general
areas, 5,104 patients living with type 1 diabetes, and 5,104 patients living with type 2
diabetes. All participants were interviewed in some form to identify perceptions on selfmanagement ability, disease stressors, difficulties with treatment regimen, and medicalpatient relationship barriers.
The outcomes of the DAWN study published by Funnell (2006) were insightful
and offered a great opportunity for improvement and change. In terms of selfmanagement, 16.2% of individuals in the study living with type 2 diabetes admitted to
full compliance with dietary and exercise recommendations and other self-care behaviors.
Physician responses estimated 2.9% self-management compliance rates among their
patients living with type 2 diabetes. Of the patients surveyed living with diabetes, 85.2%
admitted to high levels of disease distress at diagnosis and 41% of patients living with
diabetes admitted to continued distress 15 years after diagnosis. The study also showed
that only 10% of patients whom had experienced disease distress were evaluated or
treated for the distress. Nurses in the study perceived higher rates of disease-related
distress and were more likely to make the association between the distress and poor
glycemic outcomes when compared to physicians. The study also found that physicians in
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the United States were the least likely to refer patients to mental health services for
disease distress. Likewise, physicians expressed their lack of knowledge regarding the
psychological distress caused by outcomes and noted the relationship between
psychological distress and poor patient outcomes.
The DAWN study as published by Funnell (2006) explored perceptions of
healthcare providers and potential barriers to glycemic control. The study showed that the
patients with more complications self-reported poor relationships with healthcare
providers and lack of access to resources. Most patients in the study reported they saw
two or fewer healthcare professionals for diabetes management, meaning that few
patients were appropriately referred to receive recommended vision screenings,
education, primary care services, and specialty services. Additionally, nearly half of
providers self-reported restricting medication use and insulin initiation as long as possible
despite guidelines and recommendations. Overall, the DAWN study showed major
barriers to the improvement of glycemic control in patients living with diabetes. Patients
living with diabetes face many psychological barriers and are likely to suffer from disease
distress that is not appropriately addressed or managed in many cases. The
interdisciplinary team is not used effectively to ensure patients living with diabetes are
appropriately monitored and prevention services are obtained. Perhaps most importantly,
providers recognized the need to have a better understanding on the psychological effects
of diabetes as they saw the relationship between distress and poor glycemic outcomes.
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The DAWN2 study was conducted in 2011, published by Joensen et al. (2017)
and evaluated patients living with diabetes, healthcare providers, and caregivers or family
members of the patients living with type 2 diabetes. Study participants came from 17
countries and 15,000 individuals living with type 1 and type 2 diabetes collectively were
surveyed. Many of the results were quite similar to the DAWN study and indicated that
13.8% of people living with diabetes had a concordant depression diagnosis and 44.6%
reported disease distress. Self-reported opinions on quality of life showed 12.2% of study
participants living with diabetes rated their quality of life as very poor or poor. Less than
half of the surveyed participants reported attainment of diabetes education. DAWN2
assessed the concerns of family members as well and found 35.3% of family members
felt the diagnosis of diabetes was a burden, 61.3% of family members had continual fears
of hypoglycemia, and 44.6% of family members felt distress and psychological changes
because of their family members diabetes diagnosis. Like in the original DAWN study,
healthcare professionals reported the need for improved diabetes education, the
improvement in self-management capability, yet lacked the ability to assist with
psychological distress or education. The DAWN2 study reiterated the high rate of disease
distress, the negative glycemic outcomes related to diabetes distress, and the need for
improvement in education as well as psychological management of distress.
Nurses play a unique role within the healthcare system and are often tasked with
changing healthcare for the better. Often, nurses work directly with patients and are able
to ascertain information, assess needs, educate, and offer care assistance (Stuij, Elling, &
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Abma, 2019). These opportunities grant the nurse a unique perspective different from
other healthcare professionals. Nurses have the ability to form a patient-nurse relationship
built on trust and mutual respect, which allows the nurse the ability to further explore
with the patient holistic health needs (Stuij et al., 2019). The nurse-patient relationship
also allows for increases in patient confidence in their abilities to manage their own
health (Davis, Johnson, McClory, & Warneck, 2019).
Nurses implement evidence-based practice to create guidelines, enforce standards,
and elicit positive change and improved healthcare outcomes (Teodorowski, Cable,
Kilburn, & Kennedy, 2019). These tasks are accomplished with application of several
foundations of nursing practice, including advocacy, quality care, and education as
established by the American Nurses Association (ANA, 2015). Research suggests that
nurses are able to more effectively improve patient outcomes and elicit positive social
change when their knowledge base is robust (Jones et al., 2018). As such, nurses educated
on the recommendations and guidelines in the treatment of postoperative glycemic
control have the ability to positively impact patient outcomes (Stuij et al., 2019). Nurses
play an integral role in the improvement of diabetes management throughout the
continuum of life (Stuij et al., 2019).
Additionally, nurses play an important role in the education of the patient (Jones
et al., 2018). Data from multiple studies suggest the importance of diabetes specific
patient education to improve the outcomes and glycemic control of patients living with
diabetes (Tan et al., 2019). Lower rates of disease knowledge result in more
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complications and poorer glycemic control (Tan et al., 2019). A nurse with disease
specific knowledge has the ability to educate a patient living with diabetes on the disease
(Jones et al., 2018). Per Jiang et al. (2017) psychological evaluation and continued
support is also required to ensure best outcomes in patients living with diabetes. Nurses
have a critical role in ensuring psychological well-being and assessments to ensure
patients are able to care for themselves. To ensure complete evaluation, nurses must also
assess barriers to care and adequate glycemic control. An individualized,
multidisciplinary approach is the only method to ensure adequate glycemic control in
people living with type 2 diabetes (Tan et al., 2019).
Local Background and Context
Rates of diabetes vary throughout the 50 states in the country, and the state of
Ohio has one of the highest rates of diabetes (CDC, 2017b; Ohio Department of Health,
2017). Though an estimated 9.4% the United States population has diabetes, the rate in
Ohio was 12.7% as of 2017 (CDC, 2017b; ADA, 2017). As of 2017, 1,279,000 Ohioans
are living with diabetes and an estimated 67,000 more individuals are diagnosed yearly
(ADA, 2017). In the state of Ohio as of 2015, diabetes was listed as the cause of death for
3,500 individuals and was noted as the 7th leading cause of death (Ohio Department of
Health, 2017).
Along with an increased prevalence of diabetes in Ohio, expenses related to
diabetes are also elevated. Data published by the ADA (2017) shows that a person living
with diabetes spends an estimated 2.3 times more on healthcare related expenses when
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compared to individuals living without diabetes. As of 2017, the direct healthcare
expenditure related to diabetes was $9 billion in Ohio. Additionally, an estimated $3.4
billion were spent on disability and time away from work related to diabetes in Ohio in
2017. Overall costs related to a diabetes diagnosis in the state of Ohio in 2017 were $12.4
billion.
The pathophysiology of type 2 diabetes, antihyperglycemic agents, and the comorbidity of obesity play a role in bone health and contribute to the need for orthopedic
surgeries and procedures (Sundararaghavan, Mazur, Evan, Liu, & Ebraheim, 2017).
Sundaraghavan et al. (2017) wrote patients living with type 2 diabetes have increased
bone mineral density related to decreased bone turnover and hyperinsulinemia. Decreased
bone turnover is identified as low type 1 cross-linked C-telopeptide and type 1 crosslinked N-telopeptde levels. Insulin like growth factor 1 (IGF-1) is a hormone that plays a
role in bone health and bone mineral density. Hyperinsulinemia is a characteristic of type
2 diabetes and is thought to act as IGF-1 creating several problems with bone health. One
known change is the result of the increased osteoblast action resulting in bone changes. A
second change in bone health is the result of the increased storage and creation of adipose
tissue noted in the bone marrow stem cell. This is the direct result of a single protein
cascade that leads to the activation of subsequent proteins and receptors.
Obesity and type 2 diabetes are commonly correlated and obesity has been shown
to effect bone health (Dutta & Ghosh, 2019; Sundararaghavan et al., 2017). Per
Sundaraghavan et al. (2017) the relationship between obesity and bone change is related
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to the increase in adipose tissues and hormones, particularly leptin. Leptin is a hormone
that decreases the creation of osteoclasts and stimulates the production of osteoblasts.
Adiponectin is another hormone associated with obesity and lower bone mineral density,
however, patients with type 2 diabetes have low levels of adiponectin, therefore, higher
levels of bone mineral density.
Several classes of antihyperglycemic agents effect bone health. Sundararaghavan
et al (2017) discussed the biguanide class of medications, which includes metformin, has
been shown to promote bone creation and bone health. The thiazolidinedione (TZD) class
of medications, which includes rosiglitazone and pioglitazone, was found to cause an
increase in fracture risk, aside from spinal fractures in women in the ACCORD study.
The GLP-1 medication class was shown to promote bone health in one study and
compromise bone health in another. The Dipeptidyl peptidase-4 (DPP-4) medication class
has a neutral effect on bone health. Sodium–glucose co-transporter 2 (SGLT2) inhibitors
work in the kidney causing a rise in phosphate and therefore elevated parathyroid
hormone levels resulting in increased bone resorption and poor bone outcomes. Lastly,
the sulfonylurea medication class may improve bone health or have neutral effects.
Overall, Sundararaghavan et al. (2017) found that patients living with diabetes
have an increased fracture risk related to medication use, disease pathophysiology, comorbidities, or other factors. Though patients living with type 2 diabetes have increased
bone mineral density in some trabecular bone, bone mineral density is weaker in
intracortical bone and the bones are more porous, which contributes to higher fracture
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risk. Obesity and elevations in BMI may account for further negative bone change related
to immobility, risk of accident or injury, and the potential for hormonal irregularities
including testosterone levels. Studies have also shown a positive correlation between
complications of diabetes including retinopathy, nephropathy, and neuropathy and risks
of fractures, especially in the hip.
With the knowledge of the increased risk of bone fractures in patients living with
type 2 diabetes, it is also important to consider the potential complications of poor health.
Per Sundararaghavan et al (2017), patients living with type 2 diabetes have slower bone
healing related to dysfunctions in production of growth hormones, collagen, failed
cartilage transfer, and defective protein synthesis. In addition to poor bone health and
poor bone healing, changes in the joint related to excess glucose and poor diabetes
control, raises the risk of the need for surgical intervention for fracture or joint problems.
Aside from poor bone and surgical healing, a primary concern is risk of infection.
Researchers have found that patients living with type 2 diabetes are two to four times
more likely to develop a postoperative infection when compared to individuals without a
type 2 diabetes diagnosis.
Poor bone health, increased fracture risk, and increased likelihood of the need for
surgical intervention to eliminate joint problems, adds to the difficulties of living life with
type 2 diabetes (Sundararaghavan et al., 2017). Injuries to the bone and surgical
interventions, especially when complicated by infections, lead to prolonged periods of
time away from work, declines in the ability to complete everyday activities, and negative
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psychological impacts including decreased perceptions of quality of life (Garg et al.,
2016). Nursing professionals are charged with caring for and ensuring the best outcomes
for patients (Jiang et al., 2017). When the patient is hospitalized following an orthopedic
procedure, the nurse must address the mental, physical, and medical needs of the patient
to return the patient to their previous health level (Jiang et al., 2017).
Role of the DNP Student
Completion of the DNP project requires complete emersion on behalf of the DNP
student. To begin the project, identification of a healthcare problem that has a great
societal impact is necessary. To determine the project focus, consideration to global,
national, and local health is imperative. On the local level, type 2 diabetes has a high
prevalence (Ohio Department of Health, 2017). With the recent addition of a healthcare
system based orthopedic group, an increase in patients living with type 2 diabetes
receiving orthopedic procedures and surgeries has been noted. Research showed the
potential for poor outcomes in patients living with type 2 diabetes following surgical
intervention within the acute care or hospital setting (Sundararaghavan et al., 2017).
Therefore, the focus of the project surrounds guideline development to assist with the
glycemic control of patients living with type 2 diabetes following orthopedic intervention
requiring hospitalization.
The DNP project is meant to elicit exemplary nursing practice and scholarship
(Root, Nunez, Velasquez, Malloch, & Porter-O’Grady, 2018). Projects should be
rigorous, use high level evidence, focus on social change, and ensure increased
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knowledge and assimilation of evidence to practice, which may lead to healthcare
improvements (Root et al., 2018). The American Association of Colleges of Nurses
(AACN, 2006) wrote of the standards for the DNP educated nurses. To complete this
project, DNP essentials I, II, III, and VI were used (AACN, 2006). The essentials require
the utilization of science and evidence, system changes and improvements, scholarship
and evidence-based practice utilization, and the multidisciplinary approach to improve
population health problems (AACN, 2006).
Through research, the importance of the nurse’s role in glycemic control is noted
(Jiang et al., 2017). Nurses play an integral role in the education and provision of selfmanagement and coping skills for the patient, as well as direct psychological and physical
healthcare needs (Jiang et al., 2017). With the understanding of the great impact nurses
have on glycemic control as well as the published guidelines citing the guidelines and
recommendations for euglycemia postoperatively, the development of a clinical practice
guideline focusing on the nurse’s role in the improvement of postoperative glycemic
control is found to be necessary (Jiang et al., 2017; ADA, 2019b). My role in the
development of the clinical practice guideline began with the identification of a problem
and continued through literature search and review to determine a potential change
implementation that would elicit positive social change and patient outcomes. Motivation
for project completion included a family and personal history of diabetes and continued
work in the endocrinology field. Personal and practice experience may lead to bias and to
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avoid this bias, I based recommendations on high quality research articles and guidelines
retrieved through a thorough search and analysis of the literature.
Role of the Project Team
I worked with several members of the University faculty, as well as mentors to
successfully complete the DNP project. Walden University provided me with a project
committee, which included a committee chair, committee member, and university
research reviewer (Walden University, 2018). Additionally, the chief academic officer
will play a role in the final approval of the project (Walden University, 2018). This
review process ensures project rigor and focus on the goals of societal change and
population health improvement (Root et al., 2018). The Appraisal of Guidelines for
Researching & Evaluation (AGREE) II instrument was used by experts in the field to
evaluate the appropriateness of the developed guideline. Following the project timeline
and approval process, the team members had several opportunities to review the material
and data supporting the clinical practice guideline (Walden University, 2018).
Because the multidisciplinary team approach is crucial to successful diabetes
management, a team within the clinical location assisted in the creation of the final
clinical practice guideline. I collaborated with the local endocrinologist, diabetes
educators, nurses on the orthopedic unit, and members of the orthopedic team. This team
approach allowed for collaborative and functional production of a clinical practice
guideline that may be easily assimilated into practice. I ensured that the project
information, progress, and goals were provided to the interdisciplinary team with time for
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personal accounts and feedback to help guide the clinical practice guideline. Team
members were updated with each submission of the project to Walden University to
ensure the entire team was aware of the project status.
Summary
As the prevalence of type 2 diabetes increases, the social and healthcare impacts
of poor control create a greater strain on society and the healthcare system (Maa, 2017).
Identification of a specific problem, poor glycemic control following an orthopedic
procedure requiring hospitalization, allowed for a focused analysis and potential
resolution through developing a clinical practice guideline. To create an effective clinical
practice guideline, reputable research must be used. Additionally, a team approach may
ensure rigorous publication and a sound clinical practice guideline to ensure a powerful
improvement in healthcare delivery and positive social change.
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Section 3: Collection and Analysis of Evidence
Introduction
Type 2 diabetes is a chronic health condition with complications that may
devastate the individual diagnosed with the disease (Hurtado & Vella, 2019). The high
prevalence rate and poor control seen in the United States result in a negative effect on
society overall (CDC, 2017b). Of special concern are postoperative wound healing
(Underwood et al., 2014). The risks of poor glycemic control include evisceration, poor
wound healing, infection, surgical failures, delay in return to normal functional ability,
and mortality (Yong et al., 2018). Specifically, orthopedic procedures that require
inpatient stays create a challenge for nurses and care providers who are attempting to
reach optimal glycemic control for the patient living with type 2 diabetes postoperatively
(Underwood et al., 2014).
The project will enhance nursing practice through the development of a practice
guideline. The guideline, a synthesized version of current research and recommendations,
may improve glycemic control in hospitalized patients following an orthopedic
procedure. The guideline will allow nurses to educate patients, advocate for patients, and
assist patients with self-management and self-efficacy to improve glycemic control
(Akiboye & Rayman, 2017). Because living with type 2 diabetes requires a great deal of
self-management, it is imperative that even within the hospital setting, nurses are
ensuring the patients have an understanding of their role in the management of the
disease when they are able to do so (Akiboye & Rayman, 2017). To achieve optimal
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management, nurses and healthcare providers need to follow a standardized guideline that
helps with glycemic control to prevent life-limiting or life-altering postoperative
complications and ensure optimal patient outcomes (Akiboye & Rayman, 2017).
Locally, in the state of Ohio, the prevalence rate of diabetes was 12.7% as of
2017, compared to a national prevalence rate of 9.4%, which means that more people in
Ohio are living with a diabetes diagnosis and that it is considerably more likely that they
would require intensive glycemic management during a hospitalization than elsewhere
(CDC, 2017b, Ohio Department of Health, 2017). It is estimated that in Ohio alone, $9
billion is spent annually on direct diabetes healthcare costs and $3.4 billion is spent on
indirect costs associated with a diabetes diagnosis (ADA, 2017). In relation to orthopedic
surgeries, researchers have also found correlations between some antihyperglycemic
agents and poor bone health, thus increasing the potential need for a fracture repair
surgery (Sundararaghavan et al., 2017). On the local level, a newly established orthopedic
practice and unit within a healthcare system, along with limited access to endocrinology
services and diabetes education, have complicated the way in which optimal
postoperative glycemic control is achieved.
To further solidify the importance of this problem, I will restate the practicefocused question and relate the question to the DNP project goals. The research
supporting the development and appropriateness of a clinical practice guideline will be
discussed and analyzed. The location of the research and guidelines as well as a
description of the research methodology and specific details on the obtainment of the
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research will be stated. The project did not include any local or organizational data and I
did not conduct any research studies individually. A summary of the approach will be
detailed and reviewed in-depth.
Practice Focused Question
The project aim is to enhance nursing practice through creation of a clinical
practice guideline to assist with the improved management of glycemic control following
an orthopedic procedure requiring an inpatient stay in the person living with type 2
diabetes. The practice-focused question was developed using the PICO format as follows:
What are the evidence-based practice recommendations for adults aged 18 years and
older living with type 2 diabetes, for glycemic management following an orthopedic
procedure requiring hospitalization? To answer this question, a thorough review of the
research and evidence was required. A thorough analysis of the recommendations and
outcomes allowed for further exploration of the impact a clinical practice guideline
standardizing postoperative glycemic control and education following an orthopedic
procedure would have on the improvement of glycemic control postoperatively. The
operational definitions used for completion of this DNP project were as follows:
Clinical practice guideline: A written work formulated through a research review
and analysis process that results in an evidence-based set of patient-focused
recommendations that may improve quality of care and patient outcomes
(American Academy of Family Physicians, [AAFP], 2019).
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Glycemic control: Within the hospital setting, glycemic targets of 100-180 or 100140 if achievable without hypoglycemia equate to glycemic control (ADA,
2019b).
Postoperative: The period of time following a surgical or operative procedure
(Mick & Guastella, 2013).
Sources of Evidence
Published recommendations and outcomes were used as sources of evidence to
ensure the practice-focused question was answered as required for this project. The
sources of evidence were in the form of peer reviewed journal articles, published
organizational guidelines and recommendations, books, and organizational and public
websites. The goal of this project was to enhance glycemic control following an
orthopedic procedure for hospitalized patients. The developed clinical practice guideline
will assist nurses as they advocate and care for these patients. To develop a thorough and
evidence-based clinical practice guideline, a literature review and synthesis was
required. A literature review is defined as an intense review and analysis of high-quality
evidence and research that allows for synthesis of appropriate guidelines (Burgers,
Brugman, & Boeynems, 2019).
To ensure the practice-focused question was addressed, a comprehensive and
thorough literature review was completed. The literature review included synthesis and
analysis of type 2 diabetes management techniques, research, and published guidelines
from national organizations. The review focused on the published works of accredited
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organizations, scholars and experts in the field, and high-quality research findings. The
following databases were used to conduct the literature review: CINAHL, PubMed,
Medline, Cochrane, and SAGE. The following search terms were used: type 2 diabetes,
postoperative, orthopedic surgery, glycemic control, self-management, self-efficacy,
guidelines, standards, education, nursing, hospitalization, inpatient, and glucose. The
literature review included publications dated 2006 to 2020.
Several reputable organizations offer guidelines, recommendations, and research
in diabetes management. The ADA (2019b) issues a yearly guideline that implicitly
states recommendations for glycemic control for hospitalized patients. The ADA
(2019b) also supports self-management education and the multidisciplinary team
approach to improve glycemic control. The American Association of Diabetes Educators
(AADE, 2019) supports diabetes self-management education and emphasizes the
importance of glycemic control through the continuum of care. Additionally, AACE
(2019a), and the Endocrine Society (Umpierrez et al., 2012) offer guidelines for the
management of type 2 diabetes through the life span and both note the importance of the
multidisciplinary team as well as education that improves self-efficacy. Lastly, as noted
in the DAWN study, attention to the patients’ perceived quality of life and the patients’
ability to self-manage their type 2 diabetes is of the utmost importance (Funnell, 2006).
The aforementioned literature review, key terms, databases, and publication
years allowed a thorough analysis and synthesis of the current literature. Collection of
the most recent and robust literature allowed for creation of an appropriate and evidence-
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based clinical practice guideline that will be used to optimize patient outcomes. As the
goal of the project was to improve postoperative glycemic control, specifically in
patients requiring an inpatient stay following an orthopedic surgery, it was important to
evaluate glycemic control during hospitalization and glycemic control following other
surgical procedures. This robust literature review of the highest quality evidence allowed
me to produce a high-quality clinical practice guideline.
Analysis and Synthesis
A clinical practice guideline is a written work formulated through a research
review and analysis process that results in an evidence-based set of patient-focused
recommendations that may improve quality of care and patient outcomes (AAFP, 2019).
Clinical practice guidelines should be composed of the highest quality, evidence-based
research that has the positive potential to influence patient outcomes and elicit social
change (AAFP, 2019). As a clinical practice guideline should include high quality
research, it is important for the developer of the clinical practice guideline as well as the
reader to understand the level and quality of evidence. A literature review includes the
formal analysis of research quality and commonly, levels of evidence are used (Johns
Hopkins Medicine, 2019).
The Oxford Centre for Evidence-Based Medicine Levels of Evidence (2011)
literature assessment offers an effective way to categorize research by quality. The levels
of evidence presented offer levels 1 through 5 based on the aim of the study, the study
type, and the quality of study (Oxford Centre, 2011). This initial grade is then transposed
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to a letter A through D with the highest quality research earning a level A grade (Oxford
Centre, 2011). For example, research aimed at prevention conducted using an individual
cohort study would receive a level 2b grade (Oxford Centre, 2011). An initial grade of 2b
translates to a letter B grade (Oxford Centre, 2011). The guideline is complex and
specific allowing for appropriate categorization of the research and the extrapolation of
high-quality research (Oxford Centre, 2011). To keep the literature organized and the
grading criteria easily accessible, a literature matrix was used (See Appendix A).
The AGREE II instrument, an in-depth tool to assist with the development of
clinical practice guidelines, was applied to ensure the quality of the clinical practice
guideline (Brouwers et al., 2010). The tool required utilization of 23 criteria levels and
six areas of appraisal (Brouwers et al., 2010). The six domains include: (a scope, (b)
stakeholder involvement, (c) rigor, (d) clarity, (e) applicability, and (f) editorial
independence (Brouwers et al., 2010). Scores were based on completeness, quality,
rigor, and overall cohesiveness and evidence-based research level of support for the
clinical practice guideline (Brouwers et al., 2010).
This tool was used by the project team members and experts in the field. As a
Walden University (2019) requirement, the AGREE II tool is used to analyze and
approve final scholarly projects. Initially, the AGREE II criteria act as a guide for
clinical practice guideline development. I self-evaluated the rough draft of the final
project using the AGREE II checklist. After initial revisions, the AGREE II instrument
was applied by the expert panel that included two endocrinologists, two endocrinology
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nurses, a diabetes educator, a registered nurse working on the orthopedic unit, an
orthopedic surgeon, and three registered nurses working in the endocrinology office. The
expert panel evaluated and graded the clinical practice guideline. When the second
revision, based on expert panel feedback was complete, the same group of experts
provided with the final revision and the instrument again graded the guideline. The
development of the clinical practice guideline was considered complete when a high
score was achieved and no further revisions were necessary.
Institutional Review Board (IRB) approval was obtained (approval #02-25-200516844) to ensure the ethical requirements of the project were met. This approval
required the completion of a document and acceptance of that document by the IRB
following the completion of the project proposal oral defense. The ethical requirements
for the project included institutional privacy, patient privacy, assurance of no data
collection, and assurance that all partner organization or institution rules and regulations
were upheld. With all matters concerning patient outcome and patients in general,
confidentiality is of the utmost importance and must be considered a top priority (Oye,
Dahl, Sorensen, & Glasdan, 209). This project did not collect or use patient data nor
entail patient participation.
Additionally, the AACN (2006) DNP Essentials were used to help guide the
scholarly project, the clinical practice guideline development, and the in-depth analysis
and review of the current research and literature. The Essentials guide the scholarly
practice of the DNP nurse by ensuring high quality evidence is translated into care
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(AACN, 2006). My adherence to the essentials was evidenced by the creation and
synthesis of a clinical practice guideline that was thoroughly assessed for quality and
rigor. Additionally, the clinical practice guideline addressed several of the DNP
Essentials including the importance of the doctorally prepared nurse to act as an integral
member of the healthcare team, enhance the profession of nursing, and exhibit nurses’
role in social change (AACN, 2006).
Summary
Type 2 diabetes is a problem of epidemic proportion that negatively affects the
physical and mental health of millions of Americans (CDC, 2017b). Specifically,
uncontrolled type 2 diabetes following an orthopedic surgery that requires hospitalization
contributes to negative outcomes for patients and places a financial and resource burden
on the healthcare system (Underwood et al., 2014). To improve patient outcomes,
research, current guidelines, and organizational data may be synthesized into a clinical
practice guideline that may inform nurses as they assist with advocacy and education to
improve patient outcomes (AAFP, 2019). To ensure rigor and quality of the clinical
practice guideline, it is vital to ensure the literature and the clinical practice guidelines are
based on high quality research that show positive health benefits and patient outcomes
(Brouwers et al., 2010). A complete analysis and synthesis of the literature along with
use of tools and grading systems is required (Brouwers et al., 2010).
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Section 4: Findings and Recommendations
Introduction
Type 2 diabetes is a problem of epidemic proportion that continues to grow
(CDC, 2017b). In America, 30.3 million people were living with a diabetes diagnosis as
of 2015 (ADA, 2019a). Type 2 diabetes is a chronic, progressive disease that may lead to
a number of microvascular, macrovascular, and psychological complications (Hurtado &
Vella, 2019). Diabetes-related distress has been associated with poor perceived quality of
life and increased rates of depression (Garg et al., 2016). The treatment algorithm for the
management of hyperglycemia requires lifestyle modifications, behavior change, and
commonly, multiple medications (ADA, 2019b).
Additionally, for people living with diabetes who require an orthopedic
procedure, hyperglycemia has many negative postoperative outcomes: evisceration, poor
wound healing, increased infection rate, prolonged hospital stay, delayed return to normal
activities, and mortality (Yong et al., 2018). Locally, in Ohio, the incidence rate of
diabetes is 12.7%, which is higher than the national population incidence rate of 9.4%
(CDC, 2017b; ADA, 2017). Poor glycemic control in general and postoperatively places
a financial and resource burden on the healthcare system and contributes to negative
societal effects noted by the financial healthcare burden (Maa, 2017).
Based on an understanding of the negative outcomes associated with type 2
diabetes, a practice-focused question was developed for this project: What are the
evidence-based practice recommendations for adults, aged 18 years and older and living
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with type 2 diabetes, for glycemic management following an orthopedic procedure that
required hospitalization? Clinical practice guidelines are developed to improve clinical
outcomes (AAFP, 2019). Several organizations have created clinical practice guidelines
addressing glycemic control postoperatively and during hospitalization (ADA, 2019b;
AACE, 2019a; Umppierrez et al., 2012). The purpose of this DNP project was to improve
patient outcomes by synthesizing the current guidelines and recommendations into a
concise practice guideline that addresses postoperative glycemic control following an
orthopedic procedure requiring hospitalization.
To create the clinical practice guideline, many sources of evidence were
reviewed. The following databases were used to obtain articles published between 2006
and 2020: CINAHL, PubMed, Medline, Cochrane, and SAGE. The following keywords
were used: type 2 diabetes, postoperative, orthopedic surgery, glycemic control, selfmanagement, self-efficacy, guidelines, standards, education, nursing, hospitalization,
inpatient, and glucose. The literature was reviewed and analyzed according to the
Oxford Centre for Evidence-based Medicine scale, Levels of Evidence to ensure highquality evidence. Additionally, the AGREE II tool was applied to the draft guideline by
experts in the field of diabetes management. The purpose of this section is to discuss the
findings, implications, and recommendations; the contribution of the DNP project team;
and study’s strengths and limitations.
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Findings and Implications
Multiple literary works were reviewed and critically analyzed for this project. The
literature reviewed focused on several aspects of living with type 2 diabetes and type 2
diabetes management in general, as well as specifically pertaining to surgical operations.
The literature review explored the effect of self-efficacy and self-management education
on glycemic control (Azami et al., 2018; Jamiszewski, O’Brian, & Lipman, 2015).
Funnell (2006) explored the psychological effect of living with diabetes. Lee et al.,
(2016) discussed the impact and negative outcomes associated with hyperglycemia
postoperatively . Additionally, the professional guidelines as stated by the ADA (2019a),
Endocrine Society (Umpierrez et al., 2012), and AACE (2019) were analyzed. The
literature review was inclusive and thorough with the aim of building a practice
guideline.
Akiboye and Rayman (2017) explored the current guidelines and
recommendations for preoperative glycemic control and evaluated the effectiveness of
current care. The researchers determined preoperative glycemic control as well as
perioperative control has an impact on surgical outcomes (Akiboye & Rayman, 2017). To
determine the specific impact of postoperative outcomes, more research and data
collection would be required. However, the research findings are valuable and the
evidence is strong.
Lee et al. (2016) completed a retrospective analysis of hyperglycemia
postoperatively. Findings of prolonged hyperglycemia extending several months
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postoperatively were established. The researchers reviewed 60 historical charts from the
point of the operation through several months postoperatively. Though the researchers
concluded the negative and prolonged effects of hyperglycemia persist for several months
postoperatively, a larger participant group would be beneficial to provide more direction
on how to prevent prolonged hyperglycemia postoperatively.
Several other studies suggested correlations of diabetes to poor surgical outcomes
as well. Underwood et al. (2014) found postoperative complications were significantly
higher in patients living with diabetes with an A1C of 8% or greater. Asida et al. (2013)
also found more negative postoperative outcomes with poor glycemic control
specifically. Penrose and Lee (2013) found that postoperative outcomes were directly
correlated to preoperative glycemic control. The researchers recommended an intense
analysis of preoperative glycemic control to decrease negative postoperative outcomes
(Penorse & Lee, 2013). These combined findings suggest the need to assess preoperative,
intraoperative, and postoperative glycemic control is important to ensure positive surgical
outcomes.
Azami et al. (2018) published a study that included 142 participants to determine
if nurse-led diabetes intervention groups would lead to improvements in diabetes control.
The participants were divided into two groups and one group received the intervention,
while the other group did not. The nurse-led intervention included self-management
education, a survey of self-efficacy, and individualized care with frequent follow-up. The
group of participants that received the nurse-led program had better outcomes as noted by
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improvement in A1C, self-efficacy, and self-management skill. Though the outcomes
were positive, the study should be explored on a larger scale with a longer follow-up
window to ensure accuracy of the study findings.
The effect of care management and self-management education on glycemic
control was explored by Janiszewski et al., 2015. Again, self-education and selfmanagement skill were positively associated with improved glycemic control and selfefficacy. The study did have some flaws, which included a limited participant size and
short follow-up time. While self-management is important, the technique of education
delivery is also important according to the research of Van Smoorenburg, Hertrojis,
Eliseen, and Melles (2019). The authors cited value in self-management education and
ability for glycemic control, however, they emphasized the need for less structured and
more individual education and care delivery.
Davis et al. (2019) cited the importance of nurse-led programs and shared medical
appointments, which led to empowerment in patients living with type 2 diabetes and also
contributed to increased self-management, self-efficacy, and glycemic control. Garg et al.
(2016) found that patients receiving diabetes care and management services from nurse
practitioners were more likely to reach glycemic targets. The researchers found 87% of
study participants receiving intervention in the form of diabetes management from nurse
practitioners met their glycemic targets. Research published by Stuij et al. (2019)
suggested that nurse patient relationships were improved when the relationship was
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cultivated out of a traditional clinic space. However, this research had few participants
and scored low on the evidence scaling (Stuji et al., 2019).
Psychological distress has also been identified as an area that should be assessed
when considering glycemic control (Armani Kian et al., 2018). The original DAWN
study included a large group of participants (Funnell, 2006). The researchers were able to
ascertain the connection between a diabetes diagnosis and disease distress (Funnell,
2006). Joensen et al. (2017) discussed the aforementioned DAWN 2 study. The
researchers determined that patients living with diabetes faced a great deal of disease
distress (). Not only were the patients living with diabetes afflicted with disease distress,
caregivers and loved ones also felt disease burden and distress. Additional research
conducted by Armani Kian et al. (2018) showed patients had improved glycemic control
and perceptions of self when they were taught stress management skills and provided
with emotional support.
Additionally, professional guidelines were reviewed to comprehensively assess
the current practice standards for postoperative glycemic management. The ADA (2019b)
Standards of Care offered guidance on management of diabetes during hospitalization
and in the special circumstance of surgery. These guidelines were created after thorough
conduct of research and exploration of findings by many experts in the field of diabetes
management. The recommendations within the Standards of Care are analyzed based on
strength of research. Additionally, the guidelines are updated yearly and more frequently
if new research and data warrants an update ensuring currency and validity.
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The ADA (2019b) offered an array of recommendations for glycemic
management. The recommendations include medication and lifestyle interventions as
well as self-management education. Specifically, the ADA recommends informal
diabetes education to teach self-management skills. Additionally, the ADA offers
guidelines on target glycemic control for patients during hospitalization and calls for
moderate intensity control to prevent both hypoglycemia and hyperglycemia and improve
patient outcomes.
The joint guideline of the ACE and AACE (2019) offers evidence-based
recommendations for the management of glycemic control. The organizations joined
together to create a treatment algorithm for type 2 diabetes in general. Additionally, a
second algorithm offered instruction on the intensification of insulin regimens. This is of
particular importance as insulin is the recommended treatment option for patients during
times of hospitalization (ADA, 2019b). The guidelines are strong and backed by two
nationally-recognized organizations depicting evidence-based findings and expert
opinion (AACE, 2019).
Lastly, Umpierrez et al. (2012) detailed the recommendations of the Endocrine
Society, another highly recognized organization. The Endocrine Society guideline depicts
the need for preoperative glycemic control. The guideline also recommends intense
management of glycemic control postoperatively to improve patient outcomes. The
guideline coincides with the guidelines and recommendations of the ADA, ACE, and
AACE as well.
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The research and professional organization guidelines offered recommendations
on the need for and way to achieve glycemic postoperatively. The research suggested the
need for preoperative glycemic management to achieve postoperative glycemic control
(Underwood et al., 2014). Additionally, the research was clear that insulin should be used
as the treatment modality during hospitalization (ADA, 2019b). The guidelines also
recognized the importance of eliminating hypoglycemia during hospitalization to prevent
negative patient outcomes (ADA, 2019b). The guidelines and recommendations also
stated the importance of the healthcare providers’ knowledge of diabetes and diabetes
management to achieve optimal glycemic goals and the need for the interdisciplinary
team (Reategui et al., 2015). The complete recommendations from the literature review
have been compiled into a clinical practice guideline (see Appendix B).
Several of the research studies did have some limitations. The work of Garg et al.
(2016) was rated as a Level 3b when applying the Oxford Centre for Evidence-Based
Levels of Medicine grading system. The publication of Sunj et al. (2019) scored a level 5
on the same grading system. These lower level research findings indicated lack of
strength in the study and findings. One of the studies also had a limited sample size,
which may discredit the findings (Lee et al., 2016). An additional limitation to the
literature review process itself was the lack of orthopedic surgery specific research.
Overall, the research findings have implications for patients living with diabetes,
healthcare providers, healthcare organizations, and society. From a patient perspective,
translating the research findings into a clinical practice guideline that may be applied in
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healthcare organizations may result in improved glycemic control and improved
postoperative outcomes. Improved glycemic outcomes may results in a variety of
improved patient outcomes including improved physical and mental health (Guo et al.,
2016). The findings also allow for healthcare providers to gain knowledge on the
treatment approaches that may improve glycemic control and patient outcomes.
Knowledgeable healthcare providers have a greater ability to improve patient outcomes
(Reategui et al., 2015).
Healthcare organizations on both a small and large scale could benefit from the
findings and recommendations to improve postoperative glycemic control. Healthcare
organizations are often graded on postoperative outcomes as well as hospital readmission
rates, both of which may be improved with better glycemic control following an
orthopedic surgery (Grover & Joshi, 2014). Additionally, glycemic control in the hospital
is imperative to keep patients safe as the risks of hypoglycemia during the hospitalization
continue after hospital discharge (ADA, 2019b). From a societal standpoint, due to the
great number of Americans living with diabetes and the potential ill consequences of
uncontrolled diabetes and postoperative outcomes associated with poor diabetes control,
the societal implications of glycemic control are great (Maa, 2017). Patients living with
type 2 diabetes have a greater ability to function within society and contribute adequately
if they achieve glycemic control (Maa, 2017). If patients living with diabetes are cared
for on both a physical and mental level, the rates of depression and distress may be
significantly decreased (Maa, 2017).
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Recommendations
The clinical practice guideline created for this project can be used by nurses to
assist with postoperative glycemic control, specifically in patients living with type 2
diabetes following an orthopedic surgery requiring hospitalization. The purpose of a
clinical practice guideline is to improve quality of care and care outcomes (Roof et al.,
2018). Improving glycemic control and decreasing the negative outcomes and
complications associated with diabetes postoperatively allow for improvements in care
and quality (ADA, 2019b). Additionally, a clinical practice guideline affords all
healthcare professionals the ability to gain knowledge and have a resource to guide the
care of patients with complex conditions.
In order to create the clinical practice guideline, many steps needed to occur.
Initially, a problem was identified. The problem was selected based on my professional
experience and notation of a problem in achieving glycemic control postoperatively,
specifically following orthopedic procedures. A thorough research review was required to
(a) identify the effects of poor glycemic control postoperatively, and (b) determine
evidence-based research and guidelines to assist with improved glycemic control
postoperatively. The evidence then required reviewing, grading, and synthesis for
translation into a clinical practice guideline.
The clinical practice guideline was created to (a) provide concise, evidencebased, and easily implementable information, (b) focus on improvement of the negative
health consequences of type 2 diabetes postoperatively, (c) improve understanding of the
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importance of preoperative glycemic control for postoperative glycemic control, (d)
ensure self-management and self-efficacy are addressed during the care of the patient
with type 2 diabetes, and (e) ensure appropriate and adequate assessment and
management of patients’ psychological distress. Although several guidelines existed to
assist with glycemic management postoperatively, the guidelines were often lengthy and
difficult to follow. The creation of one inclusive clinical practice guideline that could be
used by those with and without prescriptive authority supports easy implementation and
more diverse utilization.
Additionally, sharing the literature depicting the poor outcomes associated with
impaired glycemic control postoperatively within the clinical practice guideline allowed
for an easier understanding of the gravity of the problem. The research reviewed also
substantially highlights the importance of preoperative glycemic control in order to
achieve improved postoperative glycemic control and outcomes (ADA, 2019b). Although
the aim of the clinical practice guideline development was specifically to improve
postoperative glycemic control, preoperative glycemic control must be achieved to
achieve postoperative glycemic control (ADA, 2019b).
The guideline also addressed self-management and self-efficacy as these are two
important contributors to glycemic control (Van Smoorenburg et al., 2019). As diabetes
is mainly self-managed, it is important to assess the patient’s knowledge base, ability to
self-manage, and self-efficacy behaviors (Van Smoorenburg et al., 2019). If the education
level, self-management ability, and self-efficacy behaviors are not optimal, education and
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advocacy is necessary to improve the patient’s ability to manage diabetes successfully
(Van Smoorenburg et al., 2019). Likewise, distress and depression are two common
conditions seen in individuals living with diabetes (Armani Kian et al., 2008; Egede et
al., 2016). Both distress and depression can prevent patients from achieving glycemic
control (Armani Kian et al., 2008; Egede et al., 2016). The guideline addresses the need
to screen patients for both diabetes distress and depression on a routine basis to ensure
patients are psychologically capable of participating in disease management.
To fulfill the purpose of clinical practice guideline development, several sections
of information, education, and recommendations were created (see Appendix B). The
first section of the clinical practice guideline discusses preoperative glycemic control.
Preoperative glycemic control is discussed in terms of (a) general diabetes management
goals, (b) lifestyle modifications, (c) medications, (d) diabetes education, selfmanagement, and self-efficacy, (e) psychological implications, and (f) the nurses’ role.
The second section of the clinical practice guideline depicts the necessary education and
recommendations to achieve intraoperative glycemic control. The third and final section
offers education and recommendations for postoperative glycemic control during a
hospitalization. Recommendations throughout the clinical practice guideline were based
on existing clinical practice guidelines, professional organization recommendations, and
evidence-based research. The recommendations were graded using the Oxford Centre for
Evidence-Based Medicine Levels of Evidence.
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Preoperative glycemic control begins with a healthcare providers’ general
knowledge base of diabetes and expected glycemic control goals. Organizations
including the ADA (2019b) and AACE (2019) offered recommendations for general
diabetes control in the form of an A1C result. Preoperatively, it was recommended that
the A1C value be as close to goal as possible and should not exceed an 8% (Underwood
et al., 2014). The A1C goal is achievable through lifestyle modification, education,
medication, and consideration of psychological factors (ADA, 2019b).
In terms of lifestyle modification, the ADA (2019b) recommended improved
nutrition, increased physical activity, improved sleep habits, and decreased alcohol and
tobacco intake to improve glycemic control. Pharmacologic management of
hyperglycemia can be achieved using the joint ACE/AACE (2019) medication algorithm
and insulin intensification guidelines. The algorithm and intensification guide are shared
in their entirety in the clinical practice guideline. Although lifestyle changes and
pharmacologic management of diabetes are crucial, continued management efforts will
likely fail if the patient is not educated on self-management techniques and does not have
a level of self-efficacy (Van Smoorenburg et al., 2019). Because of this, a portion of the
guideline is dedicated to the current recommendations for diabetes self-management
education. The current recommendations seek to ensure clinicians are educated on the
usefulness of diabetes education, the availability of the program, and methods to evaluate
patients for the need for additional self-management and disease education (AADE,
2019).
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The initial section of the guideline discusses the need to evaluate the
psychological impact of type 2 diabetes. As previously established, rates of diabetes
distress are high in individuals living with diabetes (Funnell, 2006; Joensen et al., 2017).
Diabetes distress can contribute to poor self-management skill and noncompliance
(Armani Kian et al., 2008). Higher rates of depression are also seen in individuals living
with diabetes (Egede et al., 2016). Depression has negative implications for glycemic
control and health in general (Egede et al., 2016). The clinical practice guideline seeks to
reiterate the high rates of distress and depression, the negative consequences of these
psychological ailments, the importance of screening for these disorders on a routine basis,
and the need for specialized care for distress and depression.
The nurse plays an integral role in assisting with the management of glycemic
control (Stuij et al., 2019). The clinical practice guideline addressed the importance of the
nurses’ role and the ability of the nurse to advocate for, educate, and care for patients
living with diabetes (Stuij et al., 2019). The role of the nurse should not be understated in
terms of postoperative glycemic management. Lastly, the guideline depicts general
recommendations preoperatively, which include cessation of certain antihyperglycemic
control, continued glycemic control, and assessment of any metabolic abnormalities
related to diabetes prior to the surgical procedure.
The second section of the clinical practice guideline discussed the
recommendations for glycemic control intraoperatively. The ADA (2019b) recommends
that glycemic control continue to be analyzed and assessed during the intraoperative
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phase. Blood sugars should be kept between 100 and 180 during the surgical procedure.
Treatment of both hypoglycemia and hyperglycemia should be initiated if blood sugars
fall outside of the parameters using the ADA guidelines for the management of diabetes
during hospitalization.
The third and final section of the clinical practice guideline discusses true
postoperative glycemic control during a hospitalization, specifically targeting patients
following an orthopedic surgery. Because conditions of the joints are negatively affected
by high levels of sugar, it is imperative to continue to maintain adequate glycemic control
during hospitalization postoperatively. High level recommendations include treatment of
hyperglycemia with basal insulin as well as sliding scale or prandial insulin plus sliding
scale insulin. Insulin therapy should be initiated with glucose levels greater than 180.
Hypoglycemia protocols should be followed per facility protocol and basal insulin dosage
should be decreased with hypoglycemia to prevent the recurrence of hypoglycemia. It is
of the utmost importance to formulate a discharge plan that allows for glycemic control
sustainability.
These recommendations are discussed in the clinical practice guideline as
published in Appendix B. The clinical practice guideline was thoroughly analyzed for
appropriateness using the AGREE II tool. The AGREE II tool is used to ensure quality
clinical practice guideline development and implementation (Brouwers et al., 2010). The
AGREE II tool requires the completion of a 23 section appraisal reviewing six important
aspects of clinical practice guideline development (Brouwers et al., 2010). The six
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domains focused on: (a) scope, (b) stakeholder involvement, (c) consistency, (d) clarity,
(e) applicability, and (f) editorial independence (Brouwers et al., 2010). Evaluators may
rank each section with a score of one to seven with a seven being the highest obtainable
score. For the purpose of this project and clinical practice guideline development, the
AGREE II tool was used to assess the clinical practice guideline by two
endocrinologists, a diabetes educator, a registered nurse working on the orthopedic unit,
an orthopedic surgeon, and three registered nurses working in the endocrinology office.
The AGREE II results are presented below:
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Table 1.
AGREE II Overall Guideline Assessment Question
AGREE II Team Member Overall Guideline Assessment
Question 1. Rate the overall quality of this
guideline
Rate

Total

Score

Appraiser 1

7

7

100%

Appraiser 2

7

7

100%

Appraiser 3

7

7

100%

Appraiser 4

7

7

100%

Appraiser 5

7

7

100%

Appraiser 6

7

7

100%

Appraiser 7

7

7

100%

Appraiser 8

7

7

100%

56

56

100%

Total

Note. AGREE II scoring ranges from 1 (lowest possible quality) through 7 (highest possible quality)
With 8 appraisers, the maximum total score possible is 56 and the minimum total score possible is 8.
The total score percentage was obtained by adding all individual scores and dividing by the total possible
points. 56/56=1; 1 x 100 = 100%

Contributions of the Doctoral Project Team
The doctoral project team consisted of two endocrinologists, a diabetes educator,
a registered nurse working on the orthopedic unit, an orthopedic surgeon, and three
registered nurses working in the endocrinology office. The interdisciplinary team
membership allowed for an enormous amount of knowledge from a nursing, diabetes
educator, endocrinology, and orthopedic perspective. An interdisciplinary doctoral
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project team was purposely selected to ensure all areas of expertise were given an
opportunity to contribute their specialized knowledge. Members of the team assisted
with the project by offering expert opinion, personal experience, and advice on reputable
organizations and sources of evidence. This information and expert opinion was helpful
for the data collection process. Additionally, upon completion of the clinical practice
guideline, the doctoral team used the AGREE II tool to assist with evaluation of the
validity and completeness of the clinical practice guideline. Completion of the AGREE
II tool appraisal and the results confirmed the strength of the clinical practice guideline.
The development of the clinical practice guideline was solely for the utilization of this
project and no implementation plans exist.
Strengths and Limitations of the Project
The clinical practice guideline has several strengths. A major strength of the
project is the robust research review completed to elicit the information entered into the
clinical practice guideline. The research review and clinical practice guideline creation
were completed with a review of more than one dozen organizational publications and
evidence-based practice research articles. Many of the recommendations of the clinical
practice guideline are strong and supported by numerous research findings. Additionally,
the research was reviewed and graded using a recognized research grading tool, the
Oxford Centre for Evidence-based Practice Levels of Evidence. Therefore, the research
quality is easily interpretable and validity assessment may be completed.
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The utilization of the interdisciplinary team for assessment of the clinical practice
guideline is a major strength of the clinical practice guideline. As identified in the CCM
(Zuccaro, 2015) and works by Grover and Joshi (2014), diabetes is a disease best treated
by an interdisciplinary team. The team members most closely effected by and most likely
to play a role in postoperative management would include an array of professionals from
the orthopedic, endocrinology, and diabetes education team. Therefore, using the expert
opinions of these clinicians as well as having the clinical practice guideline reviewed by
these individuals allows for assurance that (a) the guideline coincides with the
recommendations of the specialties, (b) the clinicians believe the clinical practice
guideline is valid, (c) the clinical practice guideline may have validity for utilization, and
(d) all specialties understand the problem and agree with a potential practice change.
Although the clinical practice guideline does offer several strengths, some
limitations are noted as well. The first limitation is the limited research pertaining
specifically to glycemic control postoperatively following an orthopedic procedure. A
number of postoperative glycemic control research articles have been published, but few
works were specifically tailored to orthopedic procedures. The findings of these research
studies may have some differences if performed on a patient group following orthopedic
surgeries. To combat this, I urge researchers to conduct studies specifically following
patients living with diabetes requiring an orthopedic surgery. The second disadvantage to
the clinical practice guideline is the simple fact that postoperative glycemic control is
greatly affected by preoperative control (Underwood et al., 2014). Therefore, despite best
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efforts to obtain glycemic control postoperatively, if an appropriate treatment algorithm is
not implemented prior to the orthopedic surgical procedure, attainment of glycemic
control following the procedure may not be possible. To lessen this disadvantage,
education should be provided to all parties to ensure the importance of preoperative
glycemic control is known.
Summary
Based on the identified diabetes epidemic and consequences of poor glycemic
control both preoperatively and postoperatively, creation of a clinical practice guideline
was warranted. The clinical practice guideline was created with knowledge of the
importance of preoperative glycemic control to assist with management of postoperative
outcomes and postoperative glycemic control. To ensure the clinical practice guideline
was well-founded, high quality literature and organizational guidelines were used to
create recommendations. Further, the doctoral project team, which included experts to
review the draft clinical practice guideline, applied the AGREE II tool to solidify the
validity of the recommendations. Clinician use of a synthesized clinical practice guideline
may improve postoperative glycemic control and decrease the negative consequences of
poor postoperative glycemic control, specifically following an orthopedic surgery
requiring a hospitalization.
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Section 5: Dissemination Plan
Introduction
The initial need for the clinical practice guideline development was based on the
local finding of poor postoperative outcomes related to poor glycemic management
postoperatively, specifically following orthopedic procedures. From there, I reviewed
evidence-based research to determine the extent of complications related to poor
postoperative glycemic control. From the literature, researchers found poor glycemic
control led to postoperative complications, including extended hospital stays, increased
risk of infection, delayed return to normal activities of daily living, and even mortality
among others (Paul & Isaac, 2018). Additional research was compiled to analyze the
degree of glycemic control needed to ensure a reduction of postoperative outcomes.
Underwood et al. (2014) found patients had a decreased risk of postoperative
complications if A1C was less than 8% prior to surgery and even better outcomes if the
A1C was 6.5% or less. For this project, a decision was made to create a clinical practice
guideline to assist with postoperative glycemic control following an orthopedic surgery
requiring hospitalization.
As the problem identified was local, dissemination to the local organization is
warranted. As the published research solidified the importance of preoperative and
postoperative glycemic control, dissemination of the clinical practice guideline would
target nursing professionals caring for the patient both preoperatively and postoperatively
(Yong et al., 2018). Members of the care team would likely include nursing professionals
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working in endocrinology, diabetes education, and orthopedics, and could be extended to
the family practice environment. Postoperatively, the audience for this guideline would
include surgical nurses, inpatient orthopedic nurses, and hospitalist nurses. The practice
guideline could also be used by physicians and physicians’ assistants.
Many stakeholders would be needed to disseminate the guideline and they are part
of the DNP project team. They include members of the endocrinology, orthopedic, and
diabetes education teams. These team members hold positions within the local healthcare
system that afford them the ability and opportunity to meet with policy makers to
disseminate the guideline into local policy. Generally, the local healthcare system would
create a task force to review the need for the policy, the validity of the policy, and the
ability to assimilate the policy into practice. After this is done, one person would be
responsible for notifying all employees of policy changes and additions.
Analysis of Self
Creation of the clinical practice guideline and project completion required that I
view myself in varying roles including as a practitioner, scholar, and project manager.
The project has allowed me to grow in a variety of ways and did present some challenges.
First, my role as a nurse practitioner allowed me the insight and knowledge of the noted
problem with glycemic management postoperatively, specifically following an
orthopedic procedure requiring a hospitalization. In my practice, I had seen firsthand the
complications associated with poor glycemic control postoperatively. This afforded me
the opportunity to identify a problem.
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After problem identification, I was able to act as a scholar. My education and
understanding of the field of research allowed me to identify a number of credible
resources. These resources were the basis of the clinical practice guideline development.
Prior to that, the resources helped me to understand and share the great impact poor
glycemic control may have on the surgical patient living with type 2 diabetes. This
research also allowed me to share the validity of the problem with my project team.
As project manager, I gained insight on how to work within a team. I gained
perspective on leadership and team membership. Although many courses have taught me
the importance of teamwork in healthcare whether the goal be working in an
interdisciplinary team for patients or working in a team to offer policy creation or change,
my professional career had not yet afforded me the opportunity to truly work as a team
member with the purpose of changing a process within the healthcare system.
Additionally, as I was the leader of this team, I was able to implement learned leadership
behaviors and gain a better understanding of the necessary skills leaders must possess in
order to work as a true team member.
Taking the leadership role was likely the biggest challenge for me. I am
accustomed to working as a team and acting as a team member, however, prior to this
project, I had not been identified as a team leader officially. The leadership role certainly
comes with expectations and the need for very effective communication. For project
completion, I worked with individuals in several specialties. Each specialty self-identified
a different top goal. From an endocrine perspective, glycemic control is of the utmost
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importance, from a diabetes education perspective ensuring the patient is educated and
able to self-manage is imperative, and from an orthopedic perspective, ensuring the
patient receives the necessary procedure to prevented a worsened problem is top priority.
As a leader, I had to ensure all of these top priorities were placed at the forefront all while
managing the best interest of the patient and the intent of the project. This project has
allowed me to grow as a nurse practitioner, scholar, team member, and leader and these
critical skills will allow me to improve my abilities to grow, learn, and lead throughout
my career.
Summary
The intent of this project was to create a clinical practice guideline that could be
easily implemented to improve glycemic control postoperatively, specifically following
an orthopedic surgery. The created clinical practice guideline outlines the essential steps
required to ensure postoperative glycemic control. As written, the clinical practice
guideline is inclusive and allows providers and nurses the ability to advocate for their
patients to ensure their physical, emotional, and educational needs are met. The clinical
practice guideline serves the purpose of a clinical practice guideline and may assist with
improvements of patient outcomes.
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Purpose
Diabetes affects 30.3 million Americans and 9.4% of the United States population
as of 2015 (American Diabetes Association, [ADA], ( 2019a). The prevalence rate
continues to increase and the annual cost of diabetes was estimated to be $327 billion as
of 2017 (ADA, 2019a). Type 2 diabetes is a complex disease that has eight noted body
disruptions known as the ominous octet (DeFronzo et al., 2013). The dysfunctions occur
at the brain, gut, pancreas, liver, and kidneys and contribute to a diabetes diagnosis
(DeFronzo et al., 2013). Because of the many body dysfunctions, it is often necessary to
use multiple medications and an intense treatment algorithm to combat hyperglycemia
and to achieve adequate glycemic control (ADA, 2019b).
The achievement of adequate glycemic control is imperative for the prevention of
complications. Uncontrolled diabetes can lead to both microvascular and macrovascular
complications (Hayfron-Benjamin et al., 2019). These complications may include heart
attack, heart disease, vascular disease, and strokes (Hayfron-Benjamin et al., 2019).
Additionally, nephropathy, retinopathy, and neuropathy are common complications seen
with uncontrolled diabetes (Hayfron-Benjamin et al., 2019). Hyperglycemia has also
been correlated to dementia, depression, and decreased quality of life (Funnell, 2006;
Simo, Ciudin, Sino-Servat, & Hernandez, 2017). The complications of diabetes may
contribute to physical, mental, and psychological abnormalities (Hayfron-Benjamin et al.,
2016; Sino et al., 2017).
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The need for surgical procedures presents special challenges to the patient living
with type 2 diabetes. First, patients living with type 2 diabetes have an increased need for
orthopedic surgeries related to average age of diagnosis, the medications effect on bone
health, and the comorbidities and complications of diabetes (Lee et al., 2016;
Sundararaghavan, Mazur, Evans, Liu, & Ebraheim, 2017). Patients living with type 2
diabetes are at risk for surgical complications including infection, evisceration, poor
healing, prolonged hospital stay, inadequate and untimely return to work and previous
lifestyle, as well as mortality (Yong et al., 2018). Both preoperative and postoperative
glycemic control appear to have an effect on the risk of surgical complications (Garg et
al., 2016; Yong et al., 2018).
As diabetes incidence continues to grow and the knowledge of the complications
and cost of the illness have spread, a variety of organizations have issued guidelines to
assist with the management of type 2 diabetes. The ADA (2019a) issues yearly
recommendations on the management of diabetes throughout varying phases of life,
including during hospitalization and postoperatively. The American Association of
Clinical Endocrinologists (AACE, 2019) and the American College of Endocrinology
(ACE) joined together to publish a type 2 diabetes treatment algorithm. The Endocrine
Society established a practice guideline for the management of diabetes during
hospitalization (Umpierrez et al., 2012). In addition to these published guidelines,
numerous researchers have published studies and opinions on both the effect of poor
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glycemic control postoperatively as well as potential procedures to improve postoperative
glycemic control.
The established guidelines are lengthy and often surround the medical
management of diabetes. Funnell (2006) published the results of the Diabetes Attitudes,
Wishes, and Needs Study that surveyed patients living with diabetes and caregivers of
patients living with diabetes to determine the impact of the disease on the daily life of the
individual living with the disease. The researchers determined that diabetes had a great
impact on the patient’s life from a psychological stance (Funnell, 2006). Azani et al.
(2018) wrote of the correlation between disease distress and lack of psychological wellbeing to poor glycemic control. This was established and discussed by Armani Kian et al.
(2018). Therefore, to improve glycemic control following an orthopedic procedure
requiring hospitalization in a patient living with type 2 diabetes, it is important to have a
guideline that clearly and concisely depicts the treatment algorithm which should include
efforts to enhance the psychological well-being of the patient living with diabetes.
A review of the current literature and guidelines shows the vast importance of
preoperative glycemic control in order to obtain postoperative glycemic control
(Underwood, Askari, Hurwitz, Chamarthi, & Garg, 2014). Underwood et al. (2014)
recommend an A1C of 8% or less prior to surgery at a minimum with A1C of 6.5% or
less for optimal postoperative glycemic control and outcomes. Suboptimal glycemic
control prior to surgery increases the risk of postoperative complications and negative
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patient outcomes (Yong et al., 2018). Because of this, it is vital to include preoperative
glycemic control recommendations in this clinical practice guideline.
The purpose of this clinical practice guideline is to:
1. Create a clinical practice guideline that is concise, evidence-based, and easily
implementable.
2. Focus on improvement of the negative health consequences of type 2 diabetes
postoperatively.
3. Create an understanding of the importance of preoperative glycemic control
for postoperative glycemic control.
4. Ensure self-management and self-efficacy are addressed during the care of the
patient with type 2 diabetes.
5. Ensure appropriate and adequate assessment and management of
psychological distress is completed.
Stakeholder Involvement and Clinical Practice Guideline Development:
This clinical practice guideline was developed using the guidelines and
recommendations of several professional organizations including ADA (2019a), AACE
(2019), and several works of high-quality research. The medical recommendations,
current guidelines, and research on preoperative glycemic control, postoperative
glycemic control, patients living with type 2 diabetes perspectives and needs, were also
used. The evidence on self-management, self-efficacy, and psychological distress were
also examined and incorporated into the clinical practice guideline development.
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Additionally, the clinical practice guideline was reviewed in its entirety and graded using
the AGREE II tool by two endocrinologists, an orthopedic surgeon, an orthopedic nurse,
two endocrinology nurses, and two diabetes educators.
Sustainability:
The clinical practice guideline should be reviewed and amended annually by the
organizational policy review board. The guideline should be updated based on high
quality and new recommendations, guidelines, and evidence-based practice findings.
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Recommendation Guide
The recommendations were graded using the Oxford Centre for Evidence-Based
Medicine Levels of Evidence (2011). The Oxford Centre for Evidence-Based Medicine
Levels of Evidence (2011) ranks sources of literature based on strength of study.
Additionally, the literature ranking is easily transferrable to a grading recommendation
using the Oxford Centre for Evidence-Based Medicine Grading Recommendation Guide.
The grades provided for recommendation range from A through D with a
recommendation grade of A holding the strongest recommendation and recommendation
grade D holding the weakest recommendation.
Questions:
The following questions acted as a guide for the Clinical Practice Guideline Development
and focused on the important role of the nurse, patient’s self-efficacy and selfmanagement skills, as well as the importance of the patient’s psychological status for
diabetes management.
1. What effect does preoperative, intraoperative, and postoperative glycemic
control have on postoperative outcomes?
2. What is the effect of diabetes self-management education on glycemic
control?
3. What is the effect of psychological distress and disease distress on glycemic
control?
4. What is the effect of the nurse-patient relationship on glycemic control?
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5. What is the treatment algorithm for glycemic control postoperatively?
6. When should an individual receive psychological assistance due to diabetes
distress?
Target Population:
Adults aged 18 and older living with a type 2 diabetes diagnosis who have undergone an
orthopedic surgical procedure requiring hospitalization.
Preoperative Measures
A1C values of 8% and higher were attributed to poor surgical outcomes which
included longer duration of hospitalization when compared to patients living with
diabetes with a preoperative A1C of 6.5% or less (Underwood et al., 2014). Akiboye and
Rayman (2017) cite increased length of stay and increased risk of pulmonary embolism
in patients living with diabetes with an A1C greater than 6.5% having cervical
laminoplasty and increased risk of mortality with an A1C greater than 7% in patients
receiving joint arthroplasty. Asida, Atallia, Gad, Eisa, and Mohamed (2013) found
hyperglycemia prior to surgery places patients living with diabetes at an increased risk
for infection, stroke, heart block, and death. Additionally, patients with well-maintained
preoperative and intraoperative blood sugars, greater than 100 were at a 34% higher risk
of postoperative complications for every 20 points blood sugar is above target (Asida et
al., 2013). Therefore, attention to preoperative glycemic control is important (Penrose &
Lee, 2013).
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Sudhakaran and Surami (2015) offer recommendations to ensuring improved
glycemic control pre, intra, and postoperatively which include the need for frequent
glucose monitoring and review, medical management strategies, and the need to rule out
current complications of hyperglycemia including diabetic ketoacidosis (DKA),
hyperglycemic hyperosmolar syndrome (HHS), and electrolyte imbalances. To manage
diabetes prior to surgery and in general, the AACE (2019) and ACE joint treatment
algorithm should be used. This algorithm calls for the titration and addition of
medications until goal glycemic control is achieved (AACE, 2019). This algorithm does
use medications that may increase the risk of complications such as dehydration and
DKA, HHS, and these medications should be held prior to surgery to reduce the risk of
DKA and dehydration (Sudhakaran and Surami, 2015).
Recommendations for preoperative glycemic control:
1. A1C should be below 8%, preferably less than 6.5% prior to elective surgery
to promote positive postoperative outcomes, and to reduce the risk of
pulmonary embolism, decrease the length of stay, and decrease the risk of
mortality (Underwood et al., 2014). Grade B
2. Preoperative glucose goal of 100 is adequate to reduce postoperative
complication rates (Asida et al., 2013). Grade A
3. Frequent monitoring of blood sugars should be completed by the patient and
reviewed frequently (ADA, 2019b). Grade D
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4. Medication adjustments should be completed following the joint AACE
(2019) and ACE type 2 diabetes treatment algorithm. Grade D
5. DKA and electrolyte imbalances should be ruled out prior to surgery
(Sudhakaran & Surami, 2015). Grade A
6. Antihyperglycemic medications should be reviewed and any class of
medications that may contribute to complications including DKA and
electrolyte imbalances should be discontinued prior to surgery. These
medications include biguanides, alpha glucosidase inhibitors,
thiazolidinediones, sulfonylureas, sodium–glucose co-transporter 2 (SGLT2)
inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, and glucagon like
peptide 1 (GLP-1) receptor agonists. Grade B
Rationale:
Preoperative glycemic control greatly effects postoperative glycemic control and
outcomes (Underwood et al., 2014). Because of the pathophysiology of the human body,
when speaking of orthopedic surgeries involving joints, glycemic control is of the utmost
importance to prevent surgical failures and complications (Akiboye & Rayman, 2017).
Clinicians, including nurses should be educated and advocate for the patient to ensure
that (1) the patient and providers are aware of the importance of glycemic control, and
potential poor outcomes associated with poor control, (2) glycemic control is achieved
using appropriate guidelines, and (3) the patient’s safety is held at the forefront of
decision making and advocacy efforts.

90
General Diabetes Management Goals
The purpose of managing type 2 diabetes is to reduce the complications
associated with the disease and improve the quality of life of patients living with the
disease (ADA, 2019a). Both the ADA (2019a) and AACE (2019) offer recommendations
for diabetes management. The recommendations include blood glucose and A1C targets.
Goal

ADA Guidelines

AACE Guidelines

A1C

<7%

<6.5%

<8% in elderly, unhealthy
Fasting Blood Sugar Level

70-130

<110

Postprandial Blood Sugar

<180

<140

Level

Lifestyle Modifications for the Management of Diabetes
Type 2 diabetes management requires an array of medical and lifestyle
contributions to adequately reach optimal glycemic targets. The first step in the treatment
algorithm is lifestyle modification through dietary, exercise and lifestyle modification
efforts (ADA, 2019b). AACE (2019) further discusses the needs of lifestyle modification
to include behavioral modifications. Lifestyle modification has the ability to delay the
onset of a type 2 diabetes diagnosis or improve the glycemic control following a
diagnosis of type 2 diabetes (ADA, 2019b). Those that do not make lifestyle
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modifications tend to have poorer glycemic control and higher rates of complications
associated with type 2 diabetes (Azami et al., 2018).
Recommendations for glycemic control through lifestyle management:
1. Improve nutrition to maintain or decreased weight (ADA, 2019b). Grade B
2. Increase physical activity to 150 minutes weekly with two days of strength
training weekly (ADA, 2019b). Grade B
3. Improve sleep habits and ensure seven hours of sleep nightly (ADA, 2019b).
Grade D
4. Minimize alcohol consumption (ADA, 2019b). Grade D
5. Avoid or quit using tobacco products(ADA, 2019b). Grade D
Rationale:
The ADA (2019a) and AACE (2019) both offer guidance on goal A1C and glucose
targets. Lifestyle modifications have been shown to improve glycemic control (ADA,
2019b). As such, clinicians, including nurses, should assist the patient in understanding
the potential benefits of improving dietary choices, increasing physical exercise,
improving sleep patterns, and decreasing tobacco and alcohol consumptions to positively
impact glycemic control (ADA, 2019b). The ADA offers several resources to assist with
nutrition improvements and two resources may be found below. From a preoperative
standpoint, these lifestyle modifications assist with the needed improvements in glycemic
control and decrease the associated risks of postoperative complications related to poor
glycemic control (Underwood et al., 2014).
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Excerpted from American Diabetes Association Patient Education Materials (2019).
What Can I Eat? Page 1-2
Medications
When A1C is elevated despite lifestyle modification, medication initiation is
recommended following an algorithm (AACE, 2019). The AACE and ACE published a
medication initiation and titration algorithm to assist with treatment plan creation for
patients living with type 2 diabetes (AACE, 2019). It is often necessary to use several
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medications to achieve optimal glycemic control (ADA, 2019a). Medications used to
treat hyperglycemia in patients living with type 2 diabetes have different mechanisms of
action and assist with glycemic control in a variety of ways (AACE, 2019). Therefore, it
is important to understand the pharmacodynamics and pharmacokinetics of each
medication to ensure improved glycemic control will result (ADA, 2019a). Though
specialized providers are knowledgeable on the disease states and medications used for
diseases, providers of non-specialty origin with extensive knowledge on the specific
disease may be an effective resource as well (Reategui et al., 2015). Additionally,
Sabione, Cavalot, Paccotti, Massucco, and Vigna-Taglianti (2018) found little difference
in patient outcomes when patients were treated in a specialty office versus a care
management team approach. If the treatment algorithm is correct, patients are compliant
and have adequate self-efficacy, the outcomes will follow (Sabione et al., 2018).
Recommendations for pharmacologic management of glycemic control:
1. Use the AACE/ACE medication algorithm for pharmacologic
management of type 2 diabetes (AACE, 2019). Grade D
2.

Use the AACE/ACE insulin titration algorithm for improved glycemic
control for individuals on insulin therapy (AACE, 2019). Grade D

3. Use resources from the ADA to improve knowledge and understanding of
the pharmacodynamics of antihyperglycemic agents (AACE, 2019).
Grade D
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Rationale:
The joint AACE/ACE (2019) algorithm was developed using extensive expert opinion
and has been continually revised to adapt to the latest pharmacologic advancements and
knowledge from diabetes research. Clinicians and nurses should ensure medication
adjustments are made or advocated for based on the most recent findings to promote
glycemic control. Again, achieving glycemic control prior to orthopedic surgery
decreases the risk of poor outcomes (Underwood et al., 2014).
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Excerpted from AACE/ACE Comprehensive Type 2 Diabetes Algorithm. (2019).
Diabetes Education, Self-Management, and Self-Efficacy
Diabetes education is warranted during the early stages of disease progression to
enhance knowledge and self-management skills (ADA, 2019a). Continued diabetes
education with an emphasis on self-management and self-efficacy is vital (Van
Smoorenburg et al., 2019). Self-management ability contributes to improved patient
outcomes (Janiszewski, O’Brien, & Lipman, 2015). Type 2 diabetes requires the attention
and decision making skills of the patient, thus, the patient must be self-reliant and have
the knowledge and ability to self-manage type 2 diabetes (Van Smoorenburg et al., 2019).

98
As the patient progresses through life or changes to health status, economic status, or
activities of daily living change, additional education and support opportunities should be
made available to the patient (Warshaw et al., 2019). Additionally, yearly educational
reviews have proven beneficial (Warshaw et al., 2019). Diabetes education programs
should be individualized to meet each and every patients needs (Van Smoorenburg et al.,
2019).
The American Association of Diabetes Educators (AADE, 2020) is a great
resource for healthcare professionals and patients living with diabetes alike. The
organization established the seven self-care behaviors as follows: (a) “healthy eating, (b)
being active, (c) monitoring, (d) taking medication, (e) problem-solving,( f) reducing risk,
and (g) healthy coping” (AADE, 2020). Additionally, the AADE in conjunction with the
CDC follow the standards for diabetes self-management education when developing
educational programs (Beck, Greenwood, & Blanton, 2017). The standards are reviewed
and updated to ensure superior development of educational programs and improved
patient outcomes (Beck et al., 2017).
10 National Standards for Diabetes Self-Management Education:
1. The program should be sustained within an organization and follow goals
and a mission set forth by the organization (Beck et al., 2017).
2. Experts in the field and stakeholders shall evaluate the program to ensure
continued efficacy (Beck et al., 2017).
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3. The program should be accessible and created with the lifestyle of the
community in mind (Beck et al., 2017).
4. The quality and rigor of the program shall be assessed by one individual
responsible entirely for ensuring the program follows the standards,
remains relevant, evidence-based, and appropriate (Beck et al., 2017).
5. The education team must include one registered nurse, dietitian,
pharmacist, or other individual with a current certified diabetes educator
license or advanced diabetes board management certification (Beck et al.,
2017).
6. The educational material should be relevant, up to date, research and
evidence based (Beck et al., 2017).
7. The program shall not be so structured so that the individual patient needs
are ignored or overshadowed. Education should be personalized (Beck et
al., 2017).
8. Education shall include continued education opportunities and ways to
receive continued support (Beck et al., 2017).
9. Participants should identify personal goals that shall be evaluated through
the educational experience (Beck et al., 2017).
10. Quality and patient outcomes should be assessed and reviewed with
implementation of change as needed (Beck et al., 2017).
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Recommendations for diabetes self-management, self-education, and self-efficacy for
improved glycemic control:
1. Use resources including the AADE website to locate and refer patients to
diabetes education (AADE, 2019). Grade D
2. Reinforce diabetes education teaching with patient interaction (Beck et al.,
2017). Grade D
3. Monitor patients for self-management and self-efficacy skill (AADE,
2019). Grade D
4. Consider referring patients to diabetes education at diagnosis. on a yearly
basis and as life circumstances change (AADE, 2019). Grade D
5. Educate patient on support and education resources such as ADA website
and AADE website (Beck et al., 2017). Grade D
6. Incorporate self-care behavior education into patient interaction (AADE,
2019). Grade D
Rationale:
Diabetes requires the ability of the patient to self-manage and use self-efficacy (AADE,
2019). Diabetes education programs that improve the patients’ ability to self-mange and
improve self-efficacy behaviors allow for improved glycemic control (Beck et al., 2017).
Clinicians including nurses should contribute to the patients’ education levels and be
aware of the resources available to the patient (Beck et al., 2017). This effort may
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contribute to improved glycemic control preoperatively and better patient outcomes
postoperatively (Underwood et al., 2014).
Psychological Impact
The psychological impact of living with diabetes should not be understated. The
initial Diabetes Attitudes, Wishes, and Needs (DAWN) study explored the psychological
implications of life with diabetes (Funnell, 2006). Participants from 13 countries were
questioned in regard to disease distress and impact of living with diabetes on their daily
life (Funnell, 2006). The study findings determined high rates of diabetes distress for
patients living with a diabetes diagnosis (Funnell, 2006). Additionally, healthcare
providers caring for individuals with diabetes also felt the burden of the disease (Funnell,
2006). Because diabetes distress and living with diabetes is a psychological burden on the
patient and caregivers the psychological feelings should be treated to ensure quality of
life (Funnell, 2006).
The DAWN 2 study further solidified the findings of the initial DAWN study
(Joensen et al., 2017). The study surveyed individuals living with diabetes as well as
caregivers and family members in 17 countries to ascertain the emotional effects of life
with diabetes (Joensen et al., 2017). An impressive 15,000 participants were surveyed
with similar findings when compared to the DAWN study (Joensen et al., 2017). Nearly
half of the participants living with diabetes admitted to diabetes distress (Joensen et al.,
2017). Disease distress and stress in general may contribute to impaired glycemic control
as well (Armani Kian et al., 2018). Research suggests that stress reduction may lead to
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improve glycemic control, improve quality of life, and improved psychological wellbeing
(Armani Kian et al., 2018). The DAWN and DAWN 2 (Funell, 2006; Joensen et al.,
2017) studies as well as the research of Armani Kian et al. (2018) suggest a correlation
between diabetes distress and poor glycemic control. Therefore, patients should be asked
about their level of distress and their psychosocial health should be assessed (ADA,
2019b).
Diabetes distress and depression are two separate diagnoses. Similarly to diabetes
distress, depression has been positively correlated to a diabetes diagnosis (Egede, Bishu,
Walker, & Bismuke, 2016). Depression also plays a role in the patients quality of life as
well as effects self-care and self-management (Egede et al., 2016). Depression as a
comorbidity is associated with increased healthcare expenditure as well (Egede et al.,
2016). It is important to screen for both diabetes distress and depression in patients with a
diabetes diagnosis. The PHQ-9 is a patient questionnaire used to assess patients level of
depression (University of Washington, 2020).
Recommendations for psychological management in the patient with type 2 diabetes
contributing to improved glycemic control:
1. Patients living with diabetes should be screened for depression using an
approved and reputable screening tool such as the PHQ-9 tool (AADE,
2019). Grade D
2. Patients living with diabetes should be assessed for disease distress such
as the PAID Scale (AADE, 2019). Grade D
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3. Patients should be referred to a mental health provider if screening for
depression or disease distress is positive (ADA, 2019b). Grade D
4. Patients should be referred to diabetes self-management education when
appropriate to enhance self-management and self-efficacy skills and to
decrease disease burden (Beck et al., 2017). Grade D
Rationale:
Both diabetes distress and depression have negative consequences and lead to poor
glycemic control (Egede et al., 2016; Joensen et al., 2017). It is imperative for clinicians,
including nurses to understand the potential negative effects of depression and distress on
the patient living with type 2 diabetes. It is also important for clinicians, including nurses
to understand the high rates of disease distress and depression seen in patients living with
diabetes (Egede et al., 2016). Because diabetes distress and depression negatively impact
glycemic control, preoperative patients especially should be screened for these disorders
to ensure good preoperative and postoperative glycemic control.
Nurses Role
Nurses are uniquely positioned in the healthcare industry and this position affords
the profession optimal access to assist patients with chronic disease (Stuij et al., 2019).
Researchers have found that using a team approach to assist with type 2 diabetes
management when the team involves a nurse allows for improved glycemic control and
patient empowerment (Janiszewskin et al., 2015). Additionally, shared medical
appointments in which patients living with type 2 diabetes meet with other patients living
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with type 2 diabetes, led by nurses resulted in improved patient empowerment (Davis,
Johnson, McClory, & Warneck, 2019). Garg et al. (2016) wrote of the positive outcomes
seen following a nurse practitioner led diabetes management program. Following the
introduction of a program led by nurse practitioners to assist with glycemic control, 87%
of participants reached glycemic target as noted by A1C value (Garg et al., 2016). The
research conducted by Stuij et al. (2019) found nurse-patient relationships were best
cultivated outside of a clinical space. Community based activities may lead to improved
nurse-patient relationships, therefore, improved glycemic control (Stuij et al., 2019).
Recommendations for nurses to assist with improvement of preoperative glycemic
control:
1. The nurse-patient relationship should be cultivated to engage patients and
assist with the improvement of glycemic control and patient outcomes
(Garg et al., 2016). Grade B
2. Nurses should be included in the team approach for diabetes management
(Janiszewskin et al., 2015). Grade B
3. Shared medical appointments led by nurses may be considered to assist
with patient empowerment and glycemic outcomes (Davis et al., 2019).
Grade B
4. Nurse practitioners offer a great resource to patients and may assist with
glycemic control, therefore, should be used as appropriate per licensure
(Garg et al., 2016). Grade B
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5. Community based programs that allow patients to interact and receive
education from nurses outside of a clinical space should be considered
(Stuij et al., 2019). Grade D
Rationale:
Nurses hold a powerful role in the patient-care experience and have the ability to
influence care and outcomes in a unique way (Stuij et al., 2019). Additionally, nurse
practitioners have the ability to continue the positive patient-nurse relationship and
provide high quality patient care (Garg et al., 2016). Achieving glycemic control
preoperatively requires attention and time that may be an interdisciplinary team including
a nurse and nurse practitioner (Davis et al., 2019). Achievement of glycemic control
preoperatively requires intense management, support, and decision making, therefore,
involvement of nurses and nurse practitioners should be considered.
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Intraoperative Glycemic Control
Glycemic control during an orthopedic surgical procedure should be monitored
closely as intraoperative glucose level also play a role in postoperative outcomes (Asida
et al., 2013). Researchers found that more intensive glycemic control during surgery
translated to fewer negative outcomes and postoperative complications when compared to
a blood sugar target of greater than 180 (Asida et al., 2013). Glycemic control may be
achieved using the guideline for treatment of diabetes during hospitalization (ADA,
2019b).
Recommendations for intraoperative glycemic control:
1. Monitor glucose levels frequently during surgery (Asida et al., 2013). Grade A
2. Use the ADA guidelines to appropriately manage glucose levels during
hospitalization (ADA, 2019b). Grade D
3. Keep blood sugar between 100 and 180 during surgical procedure to improve
patient outcomes and decrease the risk of postoperative complications (Asida
et al., 2013). Grade A
Rationale:
Just as noted with preoperative glycemic control, intraoperative glycemic control must be
achieved in order to achieve postoperative glycemic control (Aside et al., 2013).
Additionally, poor glycemic control intraoperatively leads to a multitude of
complications not dissimilar to poor postoperative glycemic control (Asida et al., 2013).
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For the patient undergoing orthopedic surgery, intraoperative control should be achieved
to decrease risks of postoperative complications (Asida et al., 2013).
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Postoperative Glycemic Control
Postoperative control relies heavily on preoperative and intraoperative control
(Penrose & Lee, 2013). Akiboye and Rayman, 2017 published research correlating
postoperative complications to perioperative glycemic control. Lee at al. (2016) found
blood sugars remain elevated for months postoperatively, significantly impacting the
daily life, perceptions of quality of life, and health outcomes of the patient living with
type 2 diabetes. Guidelines suggesting appropriate care approaches postoperatively and
during hospitalizations have been published by the ADA (2019 a), the AACE (2019) as
well as the Endocrine Society (Umpierrez et al., 2012). These recommendations are
lengthy and intricate, therefore, may not be followed appropriately. To improve
postoperative glycemic control, a synthesis of the organizational guidelines and
recommendations has been created to allow for ease of use with the aim of improving
patient outcomes in terms of glycemic control and reduction of complications associated
with glycemic imbalances postoperatively.
Treatment Recommendations during hospitalization:
1. An A1C should be checked on all patients with known diabetes if one has
not been performed in the last 3 months and also for all individuals with a
blood sugar level above 140 (ADA, 2019b). Grade D
2. Though a sliding scale should not be used solely, a correction scale should
be ordered in order to correct hyperglycemia in addition to a basal insulin
when required (ADA, 2019b). Grade B
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3. A combination of basal, prandial, and correction insulin is recommended
for glycemic control during hospitalization (ADA, 2019b). Grade A
4. Diabetes education, endocrinology, or other specialized care provider
should be consulted to assist with glycemic management (ADA, 2019b).
Grade D
5. Insulin therapy should begin with a blood glucose level above 180 (ADA,
2019b). Grade A
6. Blood glucose level targets should be 140-180 for most individuals, 110140 if the patient is able to tolerate and is not on a critical care unit (ADA,
2019b). Grade B
7. Blood sugar should be checked at bedside before meals and at bedtime for
patients eating (ADA, 2019b). Grade D
8. Blood sugars should be checked every four to six hours for patients unable
to eat (ADA, 2019b). Grade D
9. Hypoglycemia in the hospital setting shall be defined as any blood sugar
reading less than 70 (ADA, 2019b). Grade B
10. If a patient has a hypoglycemia event, the pre-established hypoglycemia
protocol should be initiated (ADA, 2019b). Grade B
11. The insulin regimen should be decreased if a hypoglycemia event occurs
(ADA, 2019b). Grade B
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12. Diabetes education and medical nutrition therapy consults should be
placed on an as needed basis (ADA, 2019b). Grade D
13. A comprehensive discharge plan shall be established prior to hospital
discharge
(ADA, 2019a). Grade B
Rationale:
Glycemic control in the hospital postoperatively is important to decrease the risk of
postoperative complications following an orthopedic procedure (ADA, 2019b;
Underwood et al., 2014). The ADA (2019b) has published established guidelines for the
management of glycemic control during hospitalization. These guidelines aim to
eliminate hypoglycemia while controlling blood glucose adequately (ADA, 2019b).
Clinicians, including nurses can use these recommendations as well as the preoperative
glycemic control recommendations including the medication algorithms to advocate for
and educate patients and other healthcare professionals on glycemic control.
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